<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Lucía González Forte on Medium]]></title>
        <description><![CDATA[Stories by Lucía González Forte on Medium]]></description>
        <link>https://medium.com/@lucia.g.forte?source=rss-9f85ec18f74d------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*x5gOLm8v8Y16MEFIZ6gRDg.jpeg</url>
            <title>Stories by Lucía González Forte on Medium</title>
            <link>https://medium.com/@lucia.g.forte?source=rss-9f85ec18f74d------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sun, 22 Nov 2026 19:47:56 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@lucia.g.forte/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Why L-Theanine and Caffeine Work Better Together: The Neuroscience of Calm Focus]]></title>
            <link>https://medium.com/@lucia.g.forte/why-l-theanine-and-caffeine-work-better-together-the-neuroscience-of-calm-focus-9ba5ff1b2536?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/9ba5ff1b2536</guid>
            <category><![CDATA[focus]]></category>
            <category><![CDATA[calm]]></category>
            <category><![CDATA[neuroscience]]></category>
            <category><![CDATA[coffee]]></category>
            <category><![CDATA[caffeine]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Thu, 08 Oct 2026 22:00:51 GMT</pubDate>
            <atom:updated>2026-10-09T20:17:12.231Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*XkZpep7StJN8Lcrq" /></figure><p>A cup of strong green tea and a cup of drip coffee can deliver comparable amounts of caffeine. Same molecule, comparable dose. And yet tea drinkers consistently describe the experience as different, across cultures and generations, in a way that the identical caffeine content has never explained.</p><p>Either millions of tea drinkers are wrong about their own experience, or something else is in the cup. Tea leaves contain L-theanine, an amino acid absent from coffee. Twenty years of controlled trials have asked what happens when it arrives alongside caffeine, and the answer has less to do with how much alertness the pairing produces than with how clean that alertness is.</p><h3>What Caffeine Does, and What It Costs</h3><p>Adenosine is the brain’s tally of time awake. , and when it binds to its receptors, it slows neural activity and pushes toward sleep. <a href="https://troscriptions.com/blogs/main/adenosine">It builds up hour by hour </a><a href="https://troscriptions.com/blogs/main/caffeine">Caffeine</a>’s trick is impersonation: it fits the same receptors without activating them, so the tally goes unread. The result is what caffeine is known for: sharper alertness and faster processing.</p><p>The cost side deserves naming. Caffeine causes vasoconstriction, a transient rise in blood pressure, and in some people, an agitation that interferes with the performance it was meant to support. In a neuroimaging trial in five boys with attention-deficit hyperactivity disorder (ADHD), caffeine alone worsened inhibitory control, making it harder rather than easier to stop an unwanted response [1].</p><h3>Where L-Theanine Fits: A Modulator, Not a Sedative</h3><p>L-theanine (N-ethyl-L-glutamine) is an amino acid structurally similar to glutamate, the brain’s primary excitatory neurotransmitter. Because it fits where glutamate fits, it can occupy glutamate’s receptors without switching them on. It does so weakly, far more weakly than glutamate itself, so the effect is a dampening rather than a blockade: excitatory signaling gets quieter, not switched off [2]. L-theanine also crosses the blood-brain barrier, the selective filter that decides which molecules reach the brain at all [3]. In mice, researchers found that its protective effects on brain tissue depended on <a href="https://troscriptions.com/blogs/main/gaba-and-l-theanine">gamma-aminobutyric acid (GABA) </a>, the brain’s main inhibitory neurotransmitter [4].</p><h4>What alpha waves do and don’t tell us</h4><p>Alpha waves are a rhythm of electrical activity, between 8 and 14 cycles per second, picked up by electrodes on the scalp. That rhythm is the evidence most often invoked to explain L-theanine, usually as shorthand for calm focus.</p><p>What the data show depends on what the brain is doing at the time. At rest, L-theanine increased alpha power at 50 mg and at 200 mg. But during active tasks, the conditions that actually matter if the goal is getting work done, the findings scatter: at 100 mg, one study found a reduction and another found nothing [5]. In one two-hour attention task, performance improved measurably while alpha stayed indistinguishable from placebo [6]. Whatever L-theanine does, alpha waves are not the readout. The result is a quieter background, and that matters most when something else is raising the volume.</p><h3>Why Caffeine and L-Theanine Together Produce Something Neither Does Alone</h3><p>The mechanistic case rests on a simple observation: caffeine and L-theanine act on independent systems. Caffeine works the arousal dial through adenosine; L-theanine works the excitatory background through glutamate and GABA. Because their targets do not overlap, the effects do not cancel, and what changes is not the quantity of alertness but its quality.</p><p>Think of a mixing board. Caffeine raises the overall level; L-theanine lowers the noise channel. The signal, focused attention, becomes more audible without the waveform changing.</p><p>The most direct evidence comes from a brain-imaging study in healthy adults, where the combination improved target-specific attention by decreasing mind wandering, measured as reduced activity in the default mode network, the brain circuit that switches on when attention drifts inward [7]. A similar pattern appeared in a trial with children with ADHD [1]. Both studies were small, but they point in the same direction as the pharmacology would predict.</p><h4>How Much Do Caffeine and L-Theanine Combined Actually Help?</h4><p>The mechanism is one question; the size of the benefit is another, and on that second question the evidence is unusually well studied for a supplement combination and unusually divided.</p><p>Whether the pairing does more than the sum of its parts depends on what you measure. Some trials found effects that neither compound produced alone, including on measures where the two showed a statistically significant interaction rather than simple addition [8,9]. Others found no advantage for the combination over caffeine alone [6,10], and in at least one case the effect was almost exactly additive [7]. Which pattern shows up seems to depend on what the brain is being asked to do.</p><h4>Attention and task-switching</h4><p>The most replicated finding is improved attention-switching, the ability to redirect focus quickly and accurately under load. The cleanest test of it compared caffeine with and without L-theanine added: the combination improved both speed and accuracy at 60 minutes and cut susceptibility to distraction at 60 and 90 minutes, while caffeine on its own moved alertness at 60 minutes and accuracy only at 90 [11]. Two further crossover trials found the same speed and accuracy gains against placebo [12,13].</p><p>The other side of the ledger belongs to L-theanine on its own. In one trial, it produced no behavioural effect at all when tested without caffeine [10]. In another, taken alone, it increased headache ratings and worsened performance on a mental arithmetic task [8]. Under emotional arousal, the picture changes again: the two compounds pulled attention in opposite directions, and the combination came out indistinguishable from placebo [14].</p><h4>Performance under stress and sleep deprivation</h4><p>L-theanine attenuated blood pressure increases during mental stress, most clearly in participants most reactive at baseline [15]. Caffeine and L-theanine together improved selective attention in young adults kept awake overnight [16], though masking the deficit is not the same as clearing it.</p><h4>Sustained attention over longer sessions</h4><p>Most trials measure performance at one or two points after intake. One followed it continuously across two hours, which is closer to how a working session actually feels. Under placebo, error rates climbed steadily, the familiar pattern of attention decaying with time on task. Caffeine cut those errors by half; L-theanine cut them by about a third [6].</p><p>Both worked. Neither worked better with the other. The researchers had expected the pairing to win and said so when it did not, offering the most plausible explanation: on a task this simple, each compound may already be doing everything it can.</p><h4>What the pooled evidence shows</h4><p>The most rigorous appraisal to date, funded primarily by tea and beverage companies, pooled 49 randomized trials, 16 comparable enough to combine statistically [5]. The verdict: attention-switching accuracy improved in both the first and second hour after intake, and reaction time improved by roughly 27 milliseconds in the second hour. Real, modest, and most consistent on tasks that ask you to redirect attention on demand.</p><p>Two qualifications. The statistical uncertainty around most results still included the possibility of no benefit. And an earlier pooled analysis had overstated the alertness effect by discarding one inconvenient study [17], a decision the newer review corrected.</p><h3>Does L-Theanine Actually Reduce Coffee Jitters?</h3><p>On the cardiovascular side, the claim holds up: adding L-theanine to caffeine has repeatedly blunted the rise in blood pressure that caffeine produces on its own [15,18]. On the subjective side, it does not.</p><p>Two findings look contradictory until you see what each one measured: one compared the pairing against caffeine alone and found no difference in jitteriness [18], and the other compared it against placebo and found less [5]. Coffee versus nothing is a lower bar than coffee versus coffee-plus-theanine, and it is not the bar most people are asking about.</p><p>The honest summary: the pairing moves the body more reliably than the mind. Blunting caffeine’s effect on blood pressure is a real effect on a real outcome. What the combination has not clearly done, in the trials built to test it, is change how caffeinated you feel.</p><h3>On Dosing and Timing</h3><p>Search for how much of each to take and one number comes back more than any other: two parts L-theanine to one part caffeine. No published trial has compared one ratio to another, so nobody has been able to identify an optimum.</p><p>What the trials did use ranges from roughly 2.4 parts L-theanine to 1 part caffeine all the way down to less than 1:1, with benefits reported across much of that spread. Among the trials pooled in the 2025 analysis, the median doses worked out close to 1:1 [5].</p><p>Adding L-theanine is not automatically an improvement. In a trial that tested a real cup of black tea alongside purified compounds, the tea produced no significant effect on any attention measure, while the purified doses did [7]. The likely reason: a standard cup delivers far less of both compounds than the doses the trials used. At those lower amounts, the balance shifted: the combination produced no measurable cognitive benefit, with the modulating effect of L-theanine outweighing the alerting effect of caffeine [19].</p><p>Both compounds peak in plasma within 30 to 60 minutes, and the cognitive effects tend to cluster in the first two hours after intake [5]. L-theanine does not shorten caffeine’s half-life, which is why afternoon use still carries a sleep cost, one of the more overlooked <a href="https://troscriptions.com/blogs/main/7-reasons-you-cant-sleep">reasons people cannot fall asleep </a>.</p><p>One caution that applies regardless of dose or timing: cardiovascular conditions, pregnancy or breastfeeding (where safety data are absent rather than reassuring), and any medication with known caffeine interactions are all reasons to talk to a practitioner before adding either compound to the mix.</p><h3>Conclusion: Better Control, Not More Stimulation</h3><p>Return to the puzzle. Tea drinkers were not wrong about their experience, and the answer was never that tea contains less caffeine. It contains something coffee does not, acting on a system caffeine never touches.</p><p>What that produces, on the tasks where it shows up, is not more alertness but better-organized alertness. The effect is most consistent on tasks that ask you to redirect attention quickly, smaller and less reliable on tasks that ask you to hold it for hours, and absent under emotional stress. Real, then, and specific enough to be worth knowing about. Whether that matters depends on what you need attention for.</p><h3>References</h3><p>1. Kahathuduwa CN, Wakefield S, West BD, et al. Effects of L-theanine-caffeine combination on sustained attention and inhibitory control among children with ADHD: a proof-of-concept neuroimaging RCT. Sci Rep. 2020;10(1):13072. doi:10.1038/s41598–020–70037–7</p><p>2. Kakuda T, Nozawa A, Sugimoto A, Niino H. Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors. Biosci Biotechnol Biochem. 2002;66(12):2683–2686. doi:10.1271/bbb.66.2683</p><p>3. Kakuda T. Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacol Res. 2011;64(2):162–168. doi:10.1016/j.phrs.2011.03.010</p><p>4. Egashira N, Hayakawa K, Osajima M, et al. Involvement of GABAA receptors in the neuroprotective effect of theanine on focal cerebral ischemia in mice. J Pharmacol Sci. 2007;105(2):211–214. doi:10.1254/jphs.SCZ070901</p><p>5. Payne ER, Aceves-Martins M, Dubost J, Greyling A, de Roos B. Effects of tea (Camellia sinensis) or its bioactive compounds L-theanine or L-theanine plus caffeine on cognition, sleep, and mood in healthy participants: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2025;83(10):1873–1891. doi:10.1093/nutrit/nuaf054</p><p>6. Foxe JJ, Morie KP, Laud PJ, Rowson MJ, de Bruin EA, Kelly SP. Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task. Neuropharmacology. 2012;62(7):2320–2327. doi:10.1016/j.neuropharm.2012.01.020</p><p>7. Kahathuduwa CN, Dhanasekara CS, Chin SH, et al. L-theanine and caffeine improve target-specific attention to visual stimuli by decreasing mind wandering: a human functional magnetic resonance imaging study. Nutr Res. 2018;49:67–78. doi:10.1016/j.nutres.2017.11.002</p><p>8. Haskell CF, Kennedy DO, Milne AL, Wesnes KA, Scholey AB. The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol. 2008;77(2):113–122. doi:10.1016/j.biopsycho.2007.09.008</p><p>9. Kahathuduwa CN, Dassanayake TL, Amarakoon AMT, Weerasinghe VS. Acute effects of theanine, caffeine and theanine-caffeine combination on attention. Nutr Neurosci. 2017;20(6):369–377. doi:10.1080/1028415X.2016.1144845</p><p>10. Kelly SP, Gomez-Ramirez M, Montesi JL, Foxe JJ. L-theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance. J Nutr. 2008;138(8):1572S-1577S. doi:10.1093/jn/138.8.1572S</p><p>11. Owen GN, Parnell H, De Bruin EA, Rycroft JA. The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutr Neurosci. 2008;11(4):193–198. doi:10.1179/147683008X301513</p><p>12. Einother SJL, Martens VEG, Rycroft JA, De Bruin EA. L-theanine and caffeine improve task switching but not intersensory attention or subjective alertness. Appetite. 2010;54(2):406–409. doi:10.1016/j.appet.2010.01.003</p><p>13. Giesbrecht T, Rycroft JA, Rowson MJ, De Bruin EA. The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness. Nutr Neurosci. 2010;13(6):283–290. doi:10.1179/147683010X12611460764840</p><p>14. Giles GE, Mahoney CR, Brunye TT, Taylor HA, Kanarek RB. Caffeine and theanine exert opposite effects on attention under emotional arousal. Can J Physiol Pharmacol. 2017;95(1):93–100. doi:10.1139/cjpp-2016–0498</p><p>15. Yoto A, Motoki M, Murao S, Yokogoshi H. Effects of L-theanine or caffeine intake on changes in blood pressure under physical and psychological stresses. J Physiol Anthropol. 2012;31(1):28. doi:10.1186/1880–6805–31–28</p><p>16. Nawarathna GS, Ariyasinghe DI, Dassanayake TL. High-dose L-theanine-caffeine combination improves neurobehavioural and neurophysiological measures of selective attention in acutely sleep-deprived young adults: a double-blind, placebo-controlled crossover study. Br J Nutr. 2025;134(3):195–204. doi:10.1017/S0007114525104169</p><p>17. Camfield DA, Stough C, Farrimond J, Scholey AB. Acute effects of tea constituents L-theanine, caffeine, and epigallocatechin gallate on cognitive function and mood: a systematic review and meta-analysis. Nutr Rev. 2014;72(8):507–522. doi:10.1111/nure.12120</p><p>18. Rogers PJ, Smith JE, Heatherley SV, Pleydell-Pearce CW. Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology. 2008;195(4):569–577. doi:10.1007/s00213–007–0938–1</p><p>19. Dodd FL, Kennedy DO, Riby LM, Haskell-Ramsay CF. A double-blind, placebo-controlled study evaluating the effects of caffeine and L-theanine both alone and in combination on cerebral blood flow, cognition and mood. Psychopharmacology. 2015;232(14):2563–2576. doi:10.1007/s00213–015–3895–0</p><p><em>Originally published at </em><a href="https://troscriptions.com/blogs/main/why-l-theanine-and-caffeine-work-better-together-the-neuroscience-of-calm-focus"><em>https://troscriptions.com</em></a><em> on October 8, 2026.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9ba5ff1b2536" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Depression Isn’t Just a Serotonin Deficiency: What’s Really Going On in the Brain?]]></title>
            <link>https://medium.com/@lucia.g.forte/depression-isnt-just-a-serotonin-deficiency-what-s-really-going-on-in-the-brain-d21b5a9822ef?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/d21b5a9822ef</guid>
            <category><![CDATA[chemistry]]></category>
            <category><![CDATA[deficiency]]></category>
            <category><![CDATA[depression]]></category>
            <category><![CDATA[brain]]></category>
            <category><![CDATA[serotonin]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Thu, 24 Sep 2026 22:00:51 GMT</pubDate>
            <atom:updated>2026-09-30T13:47:15.660Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*BgweKAZWPyaMHu1q" /></figure><p>Somewhere in the last thirty years, a story about the brain became common knowledge: “depression is a chemical imbalance.” Serotonin is low; a pill corrects the deficit. The logic is clean, the narrative satisfying, and the number of people who have heard some version of it is enormous. The problem is that <a href="https://troscriptions.com/blogs/main/the-chemical-imbalance-theory-of-depression-what-modern-research-says">the evidence never quite supported it </a>.</p><p>In 2023, a group of scientists reviewed decades of research on serotonin and depression and found no consistent evidence that people with depression have lower serotonin levels or activity than those without it [1].</p><p>This article goes past the serotonin headline and into what current neuroscience actually shows: a set of biological systems, including stress, inflammation, brain plasticity, and genetics, that interact in ways that are far more interesting, and far more actionable, than a leaky neurotransmitter tank.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*jzBkBkEBSrfHnGkd" /></figure><h3>Why the “Low Serotonin” Theory Falls Short</h3><p>The serotonin hypothesis wasn’t invented out of thin air. It emerged from real observations in the 1960s, when researchers noticed that drugs affecting monoamine neurotransmitters (serotonin, dopamine, norepinephrine) also affected mood. It gained enormous traction in the 1990s with the rise of selective serotonin reuptake inhibitors (SSRIs) like Prozac ®[2]. The logic felt intuitive: if a drug that raises serotonin helps depression, then depression must involve low serotonin.</p><p>The problem is that intuitive logic isn’t always right. SSRIs raise serotonin within hours, but their antidepressant effects take weeks to emerge, a timing mismatch that suggests something more complex is going on downstream. And when researchers tried to directly test the low-serotonin hypothesis by measuring serotonin metabolites in blood and cerebrospinal fluid, imaging serotonin receptors, or experimentally depleting serotonin in healthy people, the results were consistently inconsistent [1].</p><p>That doesn’t mean serotonin is irrelevant. It plays a genuine role in <a href="https://troscriptions.com/blogs/main/how-antidepressants-ssris-actually-work-beyond-the-serotonin-imbalance-theory">mood regulation, emotional processing, and social behavior </a>, but it’s one instrument in a very large orchestra.</p><h3>A Better Model: Depression as a Whole-System Condition</h3><p>Think of your brain and body less like a single engine with one thing that can go wrong, and more like an interconnected infrastructure, where multiple systems run simultaneously, and each one affects the others. Depression, in this view, is what happens when several of those systems end up under prolonged strain at once.</p><p>Modern research increasingly supports this picture. Depression is better understood as a multifactorial, heterogeneous condition, meaning it doesn’t have one cause and it doesn’t look the same in every person [3]. Some people’s depression is driven primarily by a dysregulated stress response; others show significant immune activation; others have altered brain circuit connectivity with reduced plasticity. Most show some combination, and this heterogeneity helps explain why the same treatment works powerfully for one person and barely at all for another.</p><p>Four interacting systems appear most consistently in the research. The first is the stress system, built around the hypothalamic-pituitary-adrenal axis. The second is the immune system, through inflammatory signaling. The third is neuroplasticity, or the brain’s capacity to rewire itself. The fourth is genetics and epigenetics, which shape how susceptibility is inherited and how the environment leaves lasting marks on gene expression. What follows is a closer look at each one.</p><h4>The Stress Response: When the alarm won’t turn off</h4><p>The hypothalamic-pituitary-adrenal axis (HPA axis) is one of the body’s main stress-response circuits, and it works a lot like a smoke alarm. When you encounter a threat, your hypothalamus signals your pituitary gland, which signals your adrenal glands to release cortisol, a hormone that mobilizes energy, sharpens alertness, and prepares you to respond. When the threat passes, a feedback loop turns the alarm off.</p><p>In people with depression, that feedback loop often fails. The alarm keeps firing. Chronic stress leads to sustained cortisol elevation, which over time disrupts the very receptors that are supposed to silence the response, a phenomenon researchers describe as HPA axis dysregulation [4]. These abnormalities appear particularly consistent in melancholic subtypes of depression, where cortisol dysregulation may directly impair cognitive function and emotional regulation [5].</p><p>The cumulative wear-and-tear on biological systems from sustained stress even has a name: allostatic load [6]. Think of it as the bill that arrives after months of running every appliance in the house at full capacity: the circuits hold up for a while, then things start to fail in unpredictable ways.</p><h4>The Immune System: Inflammation, an unexpected player in mood</h4><p>One of the more elegant explanatory frameworks here is the concept of sickness behavior. When your immune system detects infection or tissue damage, it produces cytokines, signaling molecules that make you feel tired, socially withdrawn, and disinterested in food or pleasure. Evolutionarily, this makes sense: when you’re fighting an infection, resting and avoiding social contact is adaptive. The problem is that in the context of chronic psychological stress or trauma, the immune system can activate similar responses without a pathogen in sight, producing what looks and feels a great deal like depression [7,9].</p><p>Importantly, elevated inflammation characterizes a subset of people with depression, not all of them [8]. This is one reason the same treatment doesn’t work for everyone, and it points toward the possibility that inflammatory biomarkers could eventually help personalize treatment approaches. Inflammation appears to specifically disrupt brain circuits involved in motivation and reward, which may help explain anhedonia, the inability to feel pleasure, that is so often central to depression [10].</p><p>Also, the stress system and the immune system do not operate in isolation. Sustained cortisol elevation can promote inflammation, and inflammation can further dysregulate the HPA axis, creating a feedback loop that compounds the effect on mood, energy, and cognition [7].</p><h4>Neuroplasticity: When the brain gets stuck in patterns</h4><p>Neuroplasticity refers to the brain’s capacity to change: to form new connections, strengthen useful pathways, and prune ones that are no longer needed. It’s what allows learning, recovery from injury, and adaptation to new circumstances. A healthy brain is, in a sense, a flexible brain.</p><p>Chronic stress and depression are associated with reduced plasticity in key brain regions, particularly the hippocampus (involved in memory and stress regulation) and the prefrontal cortex (involved in decision-making, emotional regulation, and perspective-taking). Under sustained stress, these areas can lose synaptic connections and show structural changes that appear to contribute to the cognitive rigidity, rumination, and difficulty shifting mental states that characterize depression [11].</p><p>A worn footpath through grass is a useful image here: walk the same route every day, and it becomes deep and hard to leave, even when a better route exists. Depressive thought patterns work similarly: repeated activation of stress circuits, combined with reduced plasticity, can make it progressively harder for the brain to access other states.</p><p>Central to the neuroplasticity story is brain-derived neurotrophic factor (BDNF), a protein that supports neuron survival, synaptic growth, and the brain’s capacity to adapt. BDNF levels are frequently reduced in people with depression, and chronic stress is a reliable suppressor of BDNF production [12].</p><h3>Genetics and Epigenetics: Why there’s no single cause, and why that’s actually good news</h3><p>Depression runs in families, but not simply or predictably. There is no single “depression gene”. Instead, genome-wide association studies (large-scale analyses that scan hundreds of thousands of genetic variants across populations) have identified over 100 genetic variants associated with depression, each contributing a small amount of risk, none determining outcome on its own [13]. Depression is polygenic, meaning many genes interact with each other and with environmental context to shape susceptibility.</p><p>This is where epigenetics becomes especially important. Epigenetics refers to changes in how genes are expressed, turned up or down, without altering the underlying DNA sequence itself. Think of it as the volume dial on a gene: the sequence doesn’t change, but how loudly it gets read does. Environmental experiences, including chronic stress, trauma, early adversity, poor sleep, and social isolation, can leave molecular marks on the genome that influence which genes get activated and to what degree [14]. These marks can persist long after the original stress has passed, which may partly explain why early-life adversity is such a robust predictor of adult depression risk.</p><p>Research into the epigenetic landscape of major depressive disorder has found consistent evidence of altered molecular marks on stress-related genes, changes that affect the HPA axis, neuroplasticity, and inflammatory signaling simultaneously [15]. In other words, epigenetic changes don’t target one system in isolation; they tend to shift the entire biological context in which depression operates.</p><p>What makes all of this less daunting than it sounds is that the biological context of depression is not static. The same environmental forces that can push these systems toward dysfunction (chronic stress, early adversity, social isolation) can, under different conditions, push them in the other direction [6].</p><h3>Where Serotonin Fits (Without Overcorrecting)</h3><p>None of this means serotonin is irrelevant. It plays a real and important role in mood regulation, emotional processing, and social behavior. A more accurate framing is that serotonin acts as a modulator across many of the systems described above: it interacts with HPA axis function, influences inflammatory signaling, and is embedded in the brain circuits governing reward and stress response [2].</p><p>SSRIs can still be genuinely helpful for many people, not because they refill the serotonin tank, but because sustained changes in serotonin signaling appear to trigger downstream effects on neuroplasticity, BDNF expression, and circuit connectivity [11]. Those changes take time to develop, which is why antidepressant effects emerge over weeks rather than hours, even though serotonin levels rise within the first doses. The drug acts fast; the brain adapts slowly.</p><p>Understanding serotonin as part of a network, rather than the whole story, also helps explain why SSRIs work well for some people and not others, why response takes weeks rather than hours, and why combining medication with therapy or lifestyle change tends to produce better outcomes than any single approach alone [3].</p><h3>What This Means for Treatment and Why It’s Not One-Size-Fits-All</h3><p>If depression involves multiple interacting biological systems rather than a single deficiency, then treatment logically benefits from a multi-layered approach, and the evidence supports exactly that:</p><ol><li>Medication can be a meaningful part of treatment for many people, particularly when depression is moderate to severe. But it works best understood as one tool among several, not a complete solution in isolation.</li><li>Psychotherapy , particularly cognitive behavioral therapy (CBT), helps retrain thought patterns and may support neuroplasticity by building new associative pathways. A meta-analysis of 115 randomized studies confirmed CBT as an effective treatment for adult depression, with effects comparable to pharmacotherapy and stronger when combined with it [16].</li><li>Lifestyle factors including exercise, sleep quality, social connection, and stress management have well-documented effects on HPA axis regulation, inflammatory signaling, BDNF levels, and epigenetic expression. These aren’t soft add-ons; they work through the same biological mechanisms that pharmaceutical treatments target [6,17].</li></ol><p>Personalization matters here more than in almost any other area of health. Because depression is heterogeneous, different systems are dominant in different people; what works powerfully for one person may do very little for another [3]. The emerging field of precision psychiatry aims to match treatments to individual biological profiles, including inflammatory markers, genetic variants, and neuroimaging data [18]. Not there yet clinically, but the direction is clear, and the rationale is sound.</p><h3>Conclusion: From One Chemical to a Complex System</h3><p>The chemical imbalance story of depression served a purpose. It made an invisible illness feel tangible and helped shift it out of the realm of moral failure. But science has moved on, and the picture that has emerged is considerably richer.</p><p>Depression is better understood as a condition that arises when multiple biological systems — the stress response, immune signaling, brain plasticity, and gene expression — interact under pressure in ways that tip mood, cognition, and motivation toward a persistent dark state. Serotonin is part of this story, but only a part.</p><p>The more nuanced view isn’t discouraging. It’s actually the opposite. A multi-system condition offers multiple points of intervention. Complexity, in this case, means options.</p><h3>References</h3><p>1.Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2023;28:3243–3256. doi:10.1038/s41380–022–01661–0</p><p>2. Andrews PW, Bharwani A, Lee KR, Fox M, Thomson JA. Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neurosci Biobehav Rev. 2015;51:164–188. doi:10.1016/j.neubiorev.2015. 01.018</p><p>5. Juruena MF, Bocharova M, Agustini B, Young AH. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review. J Affect Disord. 2018;233:45–67. doi:10.1016/j.jad.2017.09.052</p><p>7. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34. doi:10.1038/nri.2015.5</p><p>10. Felger JC. Imaging the Role of Inflammation in Mood and Anxiety-related Disorders. Curr Neuropharmacol. 2018;16(5):533–558. doi:10.2174/ 1570159X15666171123201142</p><p>12. Castren E, Monteggia LM. Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action. Biol Psychiatry. 2021;90(2):128–136. doi:10.1016/j.biopsych.2021. 05.008</p><p>14. Klengel T, Binder EB. Epigenetics of Stress-Related Psychiatric Disorders and Gene x Environment Interactions. Neuron. 2015;86(6):1343–1357. doi:10.1016/j.neuron.2015.05. 036</p><p>15. Yuan M, Yang B, Rothschild G, et al. Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. Signal Transduct Target Ther. 2023;8:309. doi:10.1038/s41392–023–01519-z</p><p>16. Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. <em>Can J Psychiatry.</em> 2013;58(7):376–385. doi:10.1177/070674371305800702</p><p>17. Kandola A, Ashdown-Franks G, Hendrikse J, Sabiston CM, Stubbs B. Physical activity and depression: Towards understanding the antidepressant mechanisms of physical activity. <em>Neurosci Biobehav Rev.</em> 2019;107:525–539. doi:10.1016/j.neubiorev.2019. 09.040</p><p>18. Kajumba MM, Kakooza-Mwesige A, Nakasujja N, Koltai D, Canli T. Treatment-resistant depression: molecular mechanisms and management. <em>Mol Biomed.</em> 2024;5(1):43. doi:10.1186/s43556–024–00205-y</p><p><em>Originally published at </em><a href="https://troscriptions.com/blogs/main/depression-isnt-just-a-serotonin-deficiency-whats-really-going-on-in-the-brain"><em>https://troscriptions.com</em></a><em> on September 24, 2026.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=d21b5a9822ef" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why Alcohol Feels Like Anxiety Relief (Until It Doesn’t): The GABA Rebound Effect Explained]]></title>
            <link>https://medium.com/@lucia.g.forte/why-alcohol-feels-like-anxiety-relief-until-it-doesnt-the-gaba-rebound-effect-explained-252c962ce48b?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/252c962ce48b</guid>
            <category><![CDATA[alcohol]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[anxiety]]></category>
            <category><![CDATA[stress]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Thu, 06 Aug 2026 21:00:31 GMT</pubDate>
            <atom:updated>2026-08-12T13:14:00.180Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*TYSkFKwpc9V7srAX" /></figure><p>You’ve had one of those days where everything went sideways at once. By 7 pm, you’re on the couch, glass of wine in hand, and within twenty minutes the edge comes off. The shoulders drop, the mental chatter quiets, and for a few hours you feel like a functional human being again. Then you wake up at 3 am, heart beating a little faster than it should, with a vague but familiar unease that no amount of scrolling will fix.</p><p>That’s not a coincidence. That’s your brain’s chemistry filing a formal complaint.</p><p>Alcohol’s relationship with anxiety is one of neuroscience’s more ironic stories: a molecule that produces short-term calm through the very same mechanisms that, over time, produce long-term dread. Understanding precisely why this happens changes how you see that evening glass, the morning after, and the slow drift some people experience from “drinking to unwind” to “drinking to function.”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*mtvA4v_SI_B0LWL3" /></figure><h3>The Brain’s Balancing Act: GABA and Its Counterpart</h3><p>Your brain is constantly managing a tension between activity and restraint. On one side, excitatory signals drive neurons to fire, keeping you alert, responsive, and engaged. On the other, an inhibitory system applies the brakes, preventing that activity from spiraling into noise.</p><p>The molecule at the center of that braking system is gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter [1]. The overall level of this inhibitory activity in the brain is called GABAergic tone. GABA works mainly through two receptor families, GABA-A and GABA-B, with GABA-A being the faster-acting and most relevant for anxiety. It operates in constant interplay with glutamate, the brain’s main excitatory signal — one pushes neurons to fire, the other holds them back. When this balance is working well, the brain stays calibrated: threats are assessed proportionally, the body doesn’t stay in a constant state of readiness, and minor inconveniences don’t register as emergencies. When it’s not, <a href="https://troscriptions.com/blogs/main/gaba-anxiety-connection-explained">anxiety rises</a> [2,3].</p><h3>How Alcohol Gets into Your Brain’s Business</h3><p>Alcohol is a central nervous system depressant, which is a technical way of saying it slows things down. But it doesn’t slow everything down equally. Ethanol has a particular affinity for two receptor systems: GABA-A, the brain’s primary inhibitory receptor, and NMDA receptors, which are key docking sites for glutamate’s excitatory action. Alcohol enhances the first and suppresses the second, a double move that hits the <a href="https://troscriptions.com/blogs/main/gaba-vs-glutamate">GABA-glutamate balance</a> from both ends at once [4,5]. For a few hours, the brake works better than it normally does and the gas pedal is a little less responsive.</p><p>The problem, as always, is what the brain does next.</p><h3>Why Alcohol Reduces Anxiety Short-Term</h3><p>When alcohol enhances GABA-A receptor activity, it makes neurons harder to activate, reducing the rate at which they fire. The amygdala, the brain’s alarm center, becomes less reactive, so threats feel less threatening. The prefrontal cortex, which normally keeps emotional responses in check, and the autonomic nervous system, which regulates heart rate and muscle tone, also quiet down, reducing the physical tension and restlessness that anxiety produces [4, 6]. The result is measurable: lower heart rate, reduced muscle tension, quieter intrusive thoughts, a sense of social ease.</p><p>But alcohol doesn’t stop there. It also triggers a modest increase in neurosteroids like allopregnanolone, hormone-like molecules that bind to GABA-A receptors and make them more sensitive to GABA itself [7]. The brake doesn’t just get pushed harder. It also becomes easier to push.</p><p>This is why reaching for a drink after a hard day makes complete sense. Not weakness, not poor coping — just pharmacology delivering on its short-term promise.</p><h3>The Brain Fights Back: Neuroadaptation</h3><p>The brain has one overriding priority: homeostasis, that being the drive to keep everything in balance. It doesn’t tolerate being pushed artificially in any direction for long. When alcohol repeatedly enhances GABA-A activity and suppresses glutamate signaling, the brain begins to compensate. It downregulates GABA-A receptors — making them fewer or less sensitive — and upregulates excitatory pathways to counteract the depressant effect [8,9].</p><p>Think of it like a thermostat. If you keep blasting the heat, the thermostat recalibrates to treat the higher temperature as the new normal. When you turn the heat off, the room feels cold even if it’s actually room temperature. The system isn’t broken; it’s adapted. But that adaptation comes at a cost.</p><p>Now the baseline state, without alcohol, is one of relatively reduced inhibition and relatively increased excitation. The internal thermostat has shifted. This is called neuroadaptation, and it’s the neurobiological foundation of alcohol tolerance: why the same amount feels weaker over time, and why stopping after a period of regular use can trigger a state of neurological hyperexcitability [4].</p><h3>The Rebound Effect: Why Anxiety Gets Worse</h3><p>When alcohol wears off, the artificially enhanced inhibitory state disappears, but the compensatory changes the brain made don’t reverse immediately. What remains is a less functional inhibitory GABA system, in a brain that has upregulated its excitatory pathways to compensate. The result is a period of net hyperexcitability that shows up in three recognizable ways:</p><h4>1. Rebound Anxiety</h4><p>The morning-after anxiety that many people recognize has a name: hangxiety. And it’s this mechanism in action. With less inhibitory tone available and excitatory systems running relatively hot, the amygdala becomes more reactive, the prefrontal cortex loses some regulatory control, and the nervous system is primed for threat detection. Small stressors feel larger. The background hum of worry is louder. Animal studies confirm this pattern of anxiety-like behavior persisting for hours after blood alcohol levels drop [10], and human data on next-day mood effects are consistent with the same picture [11].</p><p>Researchers describe this same neurobiological state in relation to <a href="https://troscriptions.com/blogs/main/gaba-anxiety-connection-explained">GABA deficiency and anxiety symptoms</a> . The difference is that here, it was pharmacologically induced overnight.</p><h4>2. Sleep Disruption</h4><p>Alcohol is one of the most commonly used sleep aids in the world and one of the least effective ones. While it does reduce sleep onset latency, meaning you fall asleep faster, it profoundly disrupts sleep architecture once blood alcohol levels start to drop. Early in the night, it suppresses REM sleep, the stage most associated with emotional processing and memory consolidation, and produces a REM rebound in the later hours that fragments sleep quality and reduces restorative slow-wave sleep [12]. You may spend eight hours in bed and wake up feeling like you didn’t sleep at all.</p><p>This matters for anxiety directly. Poor sleep erodes GABAergic tone, which worsens anxiety, which further disrupts sleep. Alcohol inserts itself into this cycle at multiple points, worsening both the sleep and the anxiety it was supposed to relieve. With chronic use, the sleep disruption persists even during abstinence [13].</p><h4>3. Increased Stress Sensitivity</h4><p>Beyond individual episodes, chronic alcohol exposure sensitizes the stress response system. The brain’s reduced inhibitory capacity means that normal stressors — the kind that would barely register before — now produce amplified responses. The threshold for anxiety shifts downward. Over time, once manageable situations start to feel overwhelming, and the pull toward alcohol as a coping mechanism intensifies [6].</p><h3>The Cycle: When Relief Becomes the Problem</h3><p>Here’s the feedback loop in plain terms. Alcohol relieves anxiety short-term, which reinforces the behavior. Alcohol then worsens anxiety through rebound and sleep disruption, which increases the drive to drink. The brain adapts to chronic alcohol exposure, raising the baseline level of anxiety without it. More alcohol is needed to achieve the same relief. And so the cycle continues.</p><p>Research on the self-medication hypothesis confirms this pattern. Among people with mood and anxiety disorders, the prevalence of self-medicating with alcohol falls between 22 and 24% [14]. The numbers make sense once you understand the pharmacology: the relief is real, it arrives quickly, and it works consistently enough to reinforce the behavior. That reliability is precisely what makes the cycle so difficult to interrupt [15].</p><h3>Why Some People Feel It More Than Others</h3><p>Not everyone who drinks experiences pronounced rebound anxiety, and that variability is real and neurobiological. Several factors influence individual susceptibility:</p><ul><li><strong>Baseline anxiety levels. </strong>People with pre-existing anxiety disorders tend to show stronger rebound effects because their stress systems are already primed for hyperreactivity, and their GABAergic systems are more sensitive to disruption [2].</li><li>Women tend to reach higher blood alcohol concentrations than men after consuming the same amount, due to differences in body composition, and show more disrupted sleep architecture in response to alcohol. These physiological differences likely influence both the intensity and duration of the rebound effect [12].</li><li><strong>Genetic variability. </strong>Individual differences in GABA-A receptor subunit composition influence how strongly people respond to alcohol and how quickly neuroadaptation occurs, which is one reason the anxiolytic effect and the rebound feel dramatically different from person to person [9].</li></ul><h3>Smarter Ways to Support Calm</h3><p>None of this means that a glass of wine is pharmacological roulette. But it does mean that using alcohol as a primary anxiety management strategy is, neurobiologically, working against yourself. The short-term relief is real. The long-term cost is also real.</p><p>The strategies with the strongest evidence for sustained support of the brain’s GABA system don’t carry a rebound. Regular physical activity has been shown to acutely increase cortical GABA levels [16], and consistent sleep is one of the most direct levers for maintaining inhibitory tone over time [13,17]. Chronic stress reduction matters too, not as an abstract wellness recommendation, but as a neurobiological necessity for preserving the systems that keep anxiety in check.</p><p>Some compounds are studied for their ability to interact with GABA receptors via mechanisms distinct from those of alcohol, without triggering the same neuroadaptive dynamics. These include kavalactones from kava, honokiol from magnolia, and other plant-derived modulators [18–20]. Much of this evidence comes from preclinical models, and clinical research in humans is still catching up.</p><p>Delivery method matters here too: the blood-brain barrier poses a real obstacle for many orally administered compounds, which is why <a href="https://troscriptions.com/blogs/main/gaba-blood-brain-barrier">formulation and route of administration</a> matter as much as the active ingredient.</p><p>Supplements can play a supporting role, but if anxiety or alcohol use are part of your day-to-day, talking to a clinician is always the better first step.</p><h3>Conclusion</h3><p>Alcohol doesn’t lie, exactly. The calm it produces is real, and reaching for a drink after a hard day makes complete neurochemical sense. The problem isn’t the relief. It’s the price the brain charges for it.</p><p>Every cycle of alcohol-driven GABA enhancement and rebound leaves the inhibitory system a little more adapted, a little less responsive, a little more dependent on the next drink to feel like baseline. The anxiety that alcohol was supposed to quiet becomes the anxiety that makes you reach for it again. That’s not a moral failure; that’s the rebound effect doing exactly what the neuroscience predicts.</p><p>Understanding this doesn’t make changing easy. But it does make the pattern legible. And a pattern you can see, whether you address it through sleep, movement, or compounds that support GABA without triggering neuroadaptation, is one you can start to interrupt.</p><h3>References</h3><p>1. Möhler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology. 2012;62(1):42–53. doi:10.1016/j.neuropharm.2011.08.040</p><p>2. Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat. 2015;11:165–175. doi:10.2147/NDT.S58841</p><p>3. Babaev O, Piletti Chatain C, Krueger-Burg D. Inhibition in the amygdala anxiety circuitry. Exp Mol Med. 2018;50(4):1–16. doi:10.1038/s12276–018–0063–8</p><p>4. Brailowsky S, García O. Ethanol, GABA and epilepsy. Arch Med Res. 1999;30(1):3–9. doi:10.1016/s0188–0128(98)00013-x</p><p>5. Möykkynön T, Korpi ER. Acute effects of ethanol on glutamate receptors. Basic Clin Pharmacol Toxicol. 2012;111(1):4–13. doi:10.1111/j.1742–7843.2012.00879.x</p><p>6. Dharavath RN, Pina-Leblanc C, Tang VM, et al. GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential. Front Neural Circuits. 2023;17:1218737. doi:10.3389/fncir.2023.1218737</p><p>7. Biggio G, Concas A, Follesa P, Sanna E, Serra M. Stress, ethanol, and neuroactive steroids. Pharmacol Ther. 2007;116(1):140–171. doi:10.1016/j.pharmthera.2007.04.005</p><p>8. Follesa P, Biggio F, Talani G, Murru L, Serra M, Sanna E, Biggio G. Neurosteroids, GABAA receptors, and ethanol dependence. Psychopharmacology (Berl). 2005;186(3):267–280. doi:10.1007/s00213–005–0126–0</p><p>9. Olsen RW, Liang J. Role of GABAA receptors in alcohol use disorders suggested by chronic intermittent ethanol (CIE) rodent model. Mol Brain. 2017;10(1):45. doi:10.1186/s13041–017–0325–8</p><p>10. Karadayian AG, Busso MJ, Feleder C, Cutrera RA. Alterations in affective behavior during the time course of alcohol hangover. Behav Brain Res. 2013;253:128–138. doi:10.1016/j.bbr.2013.07.011</p><p>11. Mackus M, van de Loo AJAE, van Neer RHP, et al. Differences in next-day adverse effects and impact on mood of an evening of heavy alcohol consumption between hangover-sensitive and hangover-resistant drinkers. J Clin Med. 2023;12(6):2090. doi:10.3390/jcm12062090</p><p>12. Colrain IM, Nicholas CL, Baker FC. Alcohol and the sleeping brain. Handb Clin Neurol. 2014;125:415–431. doi:10.1016/B978–0–444–62619–6.00024–0</p><p>13. Chellappa SL, Aeschbach D. Sleep and anxiety: from mechanisms to interventions. Sleep Med Rev. 2022;61:101583. doi:10.1016/j.smrv.2021.101583</p><p>14. Turner S, Mota N, Bolton J, Sareen J. Self-medication with alcohol or drugs for mood and anxiety disorders: a narrative review of the epidemiological literature. Depress Anxiety. 2018;35(9):851–860. doi:10.1002/da.22771</p><p>15. Hawn SE, Cusack SE, Amstadter AB. A systematic review of the self-medication hypothesis in the context of posttraumatic stress disorder and comorbid problematic alcohol use. J Trauma Stress. 2020;33(5):699–708. doi:10.1002/jts.22521</p><p>16. Maddock RJ, Casazza GA, Fernandez DH, Maddock MI. Acute modulation of cortical glutamate and GABA content by physical activity. J Neurosci. 2016;36(8):2449–2457. doi:10.1523/JNEUROSCI.3455–15.2016</p><p>17. Park S, Kang I, Edden RAE, Namgung E, Kim J, Kim J. Shorter sleep duration is associated with lower GABA levels in the anterior cingulate cortex. Sleep Med. 2020;71:1–7. doi:10.1016/j.sleep.2020.02.018</p><p>18. Chua HC, Christensen ETH, Hoestgaard-Jensen K, et al. Kavain, the major constituent of the anxiolytic kava extract, potentiates GABA-A receptors: functional characteristics and molecular mechanism. PLoS One. 2016;11(6):e0157700. doi:10.1371/journal.pone.0157700</p><p>19. Borgonetti V, Governa P, Manetti F, Miraldi E, Biagi M, Galeotti N. A honokiol-enriched <em>Magnolia officinalis</em> Rehder &amp; E.H. Wilson bark extract possesses anxiolytic-like activity with neuroprotective effect through the modulation of CB1 receptor. <em>J Pharm Pharmacol</em>. 2021;73(9):1161–1168. doi:10.1093/jpp/rgab067</p><p>20. Savage K, Firth J, Stough C, Sarris J. GABA-modulating phytomedicines for anxiety: a systematic review of preclinical and clinical evidence. Phytother Res. 2018;32(1):3–18. doi:10.1002/ptr.5940</p><p><em>Originally published at </em><a href="https://troscriptions.com/blogs/main/why-alcohol-feels-like-anxiety-relief-until-it-doesnt-the-gaba-rebound-effect-explained"><em>https://troscriptions.com</em></a><em> on August 6, 2026.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=252c962ce48b" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why Your Brain Won’t Slow Down: The GABA-Anxiety Connection Explained]]></title>
            <link>https://medium.com/@lucia.g.forte/why-your-brain-wont-slow-down-the-gaba-anxiety-connection-explained-81556b51b462?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/81556b51b462</guid>
            <category><![CDATA[gaba]]></category>
            <category><![CDATA[brain]]></category>
            <category><![CDATA[anxiety]]></category>
            <category><![CDATA[stress]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Thu, 11 Jun 2026 22:00:11 GMT</pubDate>
            <atom:updated>2026-06-12T14:51:46.687Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*DwaJ-rWMvdcyfVRw" /></figure><p>You know the scene. It’s nearly midnight, the room is dark, and your brain has decided that right now is the perfect moment to replay every awkward thing you said last week, draft a mental grocery list, and run three worst-case scenarios in parallel. Forty tabs open, none of them loading properly, and no way to close any of them. If your mind has ever felt like that, you’re not imagining it. What you’re experiencing has a neurobiological explanation.</p><p>Anxiety isn’t only a psychological problem. Neuroscience increasingly frames it as a problem of balance between the brain’s excitatory machinery and its inhibitory counterpart. The key player on the inhibitory side is GABA (gamma-aminobutyric acid), your brain’s primary braking system. This article unpacks what GABA is, what happens when it underperforms, how that maps to the symptoms you feel, and what the evidence actually says about supporting it.</p><h3>Meet GABA: The Brain’s Natural Brake Pedal</h3><p>GABA is the brain’s primary inhibitory neurotransmitter. While molecules like dopamine, norepinephrine, and glutamate are associated with activation and arousal, GABA does the opposite: it reduces the likelihood that neurons will fire. It does this mainly through two receptor families, GABA-A and GABA-B, with GABA-A being the faster-acting and most clinically relevant for anxiety [1]. This GABA-driven inhibitory activity — often referred to as GABAergic signaling — is what keeps neural excitation in check.</p><p><a href="https://troscriptions.com/blogs/main/gaba-vs-glutamate">The interplay between GABA and glutamate </a>, the brain’s primary excitatory neurotransmitter, is called the excitatory/inhibitory balance, one of the most fundamental principles in neuroscience [2]. Think of it like a car: glutamate is the gas pedal, GABA is the brake; you need both to drive safely [3]. When this balance tips toward excitation, the result can be excessive neural firing that manifests as anxiety, restlessness, or panic [4]. What matters isn’t only how much GABA you have, but whether it’s doing its job relative to the excitatory pressure it’s up against.</p><h3>What Does “GABA Deficiency” Really Mean?</h3><p>It’s tempting to think of “ <a href="https://troscriptions.com/blogs/main/gaba-deficiency">GABA deficiency</a>” as something you can simply measure and fix. But the reality is more nuanced. GABA-related dysfunction in anxiety can reflect several different problems at once:</p><ul><li>Reduced GABA release, particularly under chronic stress [1,5].</li><li>Altered GABA-A receptor sensitivity so GABA is present but not effectively registered by the cell [6].</li><li>An overactive glutamate system that overwhelms normal inhibitory tone [3].</li></ul><p>There’s also a measurement challenge worth naming. Brain GABA is genuinely difficult to quantify: magnetic resonance spectroscopy (MRS) offers a regional window, but plasma GABA levels don’t reliably reflect central nervous system activity [4]. What we can say with confidence is that the GABAergic system appears consistently dysregulated in anxiety disorders, and that dysregulation has real, felt consequences.</p><h3>From Neurochemistry to Symptoms: How Low GABA Feels</h3><p>Whichever mechanism is at play, the downstream effects show up in ways anyone who has dealt with anxiety will recognize. Here’s what they tend to look like in practice:</p><h4>1. Racing Thoughts</h4><p>The prefrontal cortex, your brain’s executive center for planning and impulse control, depends on interneurons — specialized neurons whose job is to regulate and dampen the activity of neighboring cells — to function smoothly. Acting like traffic controllers, they prevent too many signals from piling up at once. When inhibitory control drops, the result is mental overcrowding: thoughts proliferating faster than they can be organized or resolved. Researchers have documented reduced prefrontal GABA levels in people under acute psychological stress, providing a neurochemical basis for the “I can’t stop my thoughts” experience [7]. The traffic controllers went on strike, and now every car is honking.</p><h4>2. Restlessness and Physical Tension</h4><p>GABA’s inhibitory role extends into the motor system and the autonomic nervous system, the branch that regulates heart rate, muscle tone, and the fight-or-flight response. GABAergic tone — the baseline level of inhibitory activity in the brain — is what keeps all of this in check. When it drops, the whole system stays switched on: muscle tension, an inability to sit still, a persistent feeling of being wired. The link between GABAergic signaling and autonomic hyperactivation is well-supported in anxiety research [1,5]. Your body and brain are in constant conversation, and both notice when the brakes slip.</p><h4>3. Panic and Hyperarousal</h4><p>At the more intense end of the spectrum, reduced GABAergic tone has been specifically implicated in panic disorder. The amygdala, the brain’s alarm center, relies heavily on inhibitory interneurons to keep its reactivity in check [8]. When those interneurons underperform, the threat detector becomes hypersensitive. Research consistently points to GABAergic dysregulation as a key neurochemical contributor to exaggerated fear responses [9]. Understanding this mechanism is what makes it targetable: many effective treatments for anxiety work, at least in part, by restoring inhibitory tone.</p><h3>The Stress Loop: Why Anxiety Can Feed Itself</h3><p>There’s a catch, though: anxiety doesn’t just arise when GABA falls short. The two feed each other, creating a self-reinforcing loop that helps explain why untreated anxiety tends to worsen over time.</p><p>Chronic stress impairs GABAergic signaling in multiple ways: it suppresses the production of neurosteroids, hormone -like molecules that keep GABA receptors responsive, and it erodes inhibitory control in the prefrontal cortex, the very region that helps regulate the amygdala’s emotional reactivity [10,11]. The result is a system that becomes progressively less equipped to manage the anxiety it’s trying to contain.</p><p>Breaking the loop requires more than managing acute symptoms; it requires building sustained inhibitory resilience. But understanding the loop is itself useful: it reframes anxiety not as a character flaw, but as a system that has been pushed into a self-sustaining pattern. And patterns can be interrupted.</p><h3>What Influences GABA Function?</h3><p>GABAergic function responds to what you do. Several modifiable factors influence how well your brain’s inhibitory system operates, and understanding them matters for anyone trying to break the anxiety-stress loop:</p><ul><li><strong>Sleep</strong> is one of the most direct levers. GABA itself plays a role in regulating sleep onset and depth, so the relationship goes both ways. But critically, sleep deprivation also appears to reduce brain GABA levels: shorter sleep duration has been associated with lower GABA concentrations in the occipital cortex [12]. The clinical implication is a familiar-looking cycle: poor sleep erodes GABAergic tone, which worsens anxiety, which further disrupts sleep [13]. Treating sleep as a cornerstone of anxiety management isn’t just good wellness advice; it’s neurochemically grounded.</li><li><strong>Physical activity</strong> is one of the best-supported behavioral interventions for anxiety, and part of the reason may be GABAergic. Research has shown that a single session of moderate exercise can acutely increase cortical GABA levels [14]. Yoga, which combines movement with breathwork and mindfulness, has similarly been shown to raise brain GABA compared to passive activities [15]. The brain rewards movement with calm. Not a bad deal.</li><li><strong>Diet</strong> plays a supporting role, though an indirect one. There’s no “eat this to fix your anxiety” formula. That said, <a href="https://troscriptions.com/blogs/main/gaba-gut-microbiota-dietary-factors">gut microbiota </a>contribute to GABA metabolism, and dietary choices that support microbial diversity, including fiber, fermented foods, and varied whole foods, may influence GABAergic pathways through the gut-brain axis [16].</li><li><strong>Substance use</strong> deserves a specific note. Alcohol and benzodiazepines work by enhancing GABA-A receptor activity, which is precisely why they feel calming in the short term and why chronic use leads to receptor downregulation. The brain, adapting to an artificial GABAergic boost, becomes less sensitive to its own GABA. Withdrawal then produces heightened anxiety partly because the system is functionally impaired [17].</li></ul><h3>Can You “Boost” GABA?</h3><p>Beyond lifestyle, many people turn to supplements in search of a more direct route. It’s a reasonable instinct, but the biology makes it complicated.</p><p>Oral GABA supplements face a fundamental obstacle: GABA is a large, charged molecule with <a href="https://troscriptions.com/blogs/main/gaba-blood-brain-barrier">difficulty crossing the blood-brain barrier </a>. Some studies report modest effects on relaxation and stress markers, but whether that reflects direct brain activity or indirect mechanisms remains unclear, and the overall evidence base is limited [18].</p><p>One angle is supporting the conditions under which GABA functions well: receptor sensitivity, neurosteroid availability, and reduced chronic stress. Another is working with compounds studied for their capacity to interact with GABA receptors more directly [19], including kavalactones from kava [20] and honokiol, a plant-derived compound that enhances GABA activity in the brain [21].</p><p>Modified forms of GABA designed to cross the blood-brain barrier more effectively represent a growing frontier in this field. Researchers are exploring chemically adjusted variants, such as Cetyl GABA, which is engineered to be more lipophilic (fat-soluble) to slip through the brain’s natural defenses more easily [16]. Another strategy involves the use of GABA analogs like gabapentin, designed as structural analogs to improve delivery to the brain [17]. Most innovatively, some approaches now look to the gut-brain axis, using genetically engineered bacteria to act as internal “factories” that provide a continuous GABA supply locally in the digestive tract [16].</p><p>However, as always, delivery method and formulation matter as much as the ingredient itself. The key principle holds regardless: the brain isn’t a machine you top up. It’s a dynamic system you influence over time, and the most durable changes tend to come from consistent habits rather than any single intervention. You can read more about ways to boost GABA <a href="https://troscriptions.com/blogs/main/7-ways-to-naturally-increase-gaba">here</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*ZxPUmrQJ3tAfYPXsj80LXQ.png" /><figcaption>The GABA-anxiety connection explained</figcaption></figure><h3>Conclusion</h3><p>Anxiety can feel like a personal failing. But what the neuroscience shows is something more mechanical and, in a way, more hopeful: it’s a system that has lost its balance. When GABA isn’t doing its job, whether because of reduced release, receptor insensitivity, or an excitatory system running too hot, the brain shifts into a kind of sustained overdrive. Racing thoughts, physical tension, and panic are not random. They’re predictable consequences of a specific kind of neurobiological dysregulation.</p><p>The stress loop makes this harder, not impossible. Building sustained inhibitory resilience requires consistent inputs: sleep, movement, and a diet that supports the gut-brain axis. For some, compounds that interact more directly with GABA receptors, or modified forms designed to reach the brain more effectively, may offer meaningful additional support.</p><p>Understanding this doesn’t replace professional support for those who need it. But it does change the frame. When you know what’s happening neurobiologically, anxiety becomes less of a mystery and more of a signal your brain is sending because something in the balance needs attention. And that, at least, is something you can work with.</p><h3>References</h3><p>1. Möhler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology. 2012;62(1):42–53. doi:10.1016/j.neuropharm.2011.08.040</p><p>2. Wen Y, Dong Z, Liu J, Axerio-Cilies P, Du Y, Li J, Chen L, Zhang L, Liu L, Lu J, Zhou N, Chuan Wu D, Wang YT. Glutamate and GABA receptor crosstalk mediates homeostatic regulation of neuronal excitation in the mammalian brain. Signal Transduct Target Ther. 2022;7(1):340. doi:10.1038/s41392–022–01148-y</p><p>3. Sears SMS, Hewett SJ. Influence of glutamate and GABA transport on brain excitatory/inhibitory balance. Exp Biol Med. 2021;246(9):1069–1083. doi:10.1177/1535370221989263</p><p>5. Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat. 2015;11:165–175. doi:10.2147/NDT.S58841</p><p>6. Felice D, Cryan JF, O’Leary OF. GABA receptors: anxiety and mood disorders. In: Current Topics in Behavioral Neurosciences. Vol 52. Springer; 2022:241–265. doi:10.1007/7854_2020_171</p><p>8. Ryazantseva M, Liiwand M, Shteinikov V, Kunnari AJ, Sulku J, Lauri SE. Parvalbumin interneurons gate amygdala excitability and response to chronic stress via kainate receptor-driven tonic GABA receptor-mediated inhibition. Mol Psychiatry. 2025;30(11):5093–5107. doi:10.1038/s41380–025–03093-y</p><p>9. Moraes ACN, Wijaya C, Freire R, Quagliato LA, Nardi AE, Kyriakoulis P. Neurochemical and genetic factors in panic disorder: a systematic review. Transl Psychiatry. 2024;14(1):294. doi:10.1038/s41398–024–02966–0</p><p>13. Chellappa SL, Aeschbach D. Sleep and anxiety: from mechanisms to interventions. Sleep Med Rev. 2022;61:101583. doi:10.1016/j.smrv.2021.101583</p><p>14. Maddock RJ, Casazza GA, Fernandez DH, Maddock MI. Acute modulation of cortical glutamate and GABA content by physical activity. J Neurosci. 2016;36(8):2449–2457. doi:10.1523/JNEUROSCI.3455–15. 2016</p><p>15. Streeter CC, Whitfield TH, Owen L, Rein T, Karri SK, Yakhkind A, Perlmutter R, Prescot A, Renshaw PF, Ciraulo DA, Jensen JE. Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J Altern Complement Med. 2010;16(11):1145–1152. doi:10.1089/acm.2010.0007</p><p>16. Jiang C, Chen Y, Sun T. From the gut to the brain, mechanisms and clinical applications of gamma-aminobutyric acid (GABA) on the treatment of anxiety and insomnia. Front Neurosci. 2025;19:1570173. doi:10.3389/fnins.2025.1570173</p><p>17. Dharavath RN, Pina-Leblanc C, Tang VM, Sloan ME, Nikolova YS, Pangarov P, Ruocco AC, Shield K, Voineskos D, Blumberger DM, Boileau I, Bozinoff N, Gerretsen P, Vieira E, Melamed OC, Sibille E, Quilty LC, Prevot TD. GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential. Front Neural Circuits. 2023;17:1218737. doi:10.3389/fncir.2023.1218737</p><p>18. Hepsomali P, Groeger JA, Nishihira J, Scholey A. Effects of oral gamma-aminobutyric acid (GABA) administration on stress and sleep in humans: a systematic review. Front Neurosci. 2020;14:923. doi:10.3389/fnins.2020.00923</p><p>19. Savage K, Firth J, Stough C, Sarris J. GABA-modulating phytomedicines for anxiety: a systematic review of preclinical and clinical evidence. Phytother Res. 2018;32(1):3–18. doi:10.1002/ptr.5940</p><p><em>Originally published at </em><a href="https://troscriptions.com/blogs/main/gaba-anxiety-connection-explained"><em>https://troscriptions.com</em></a><em> on June 11, 2026.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=81556b51b462" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Rhodiola rosea vs. Ashwagandha and Ginseng: Which Adaptogen Matches Your Stress Profile?]]></title>
            <link>https://medium.com/@lucia.g.forte/rhodiola-rosea-vs-ashwagandha-and-ginseng-which-adaptogen-matches-your-stress-profile-e826e954d806?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/e826e954d806</guid>
            <category><![CDATA[adaptogens]]></category>
            <category><![CDATA[stess-management]]></category>
            <category><![CDATA[ashwagandha]]></category>
            <category><![CDATA[ginseng]]></category>
            <category><![CDATA[rhodiola-rosea]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Thu, 21 May 2026 21:00:11 GMT</pubDate>
            <atom:updated>2026-05-28T17:42:56.501Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*fW7rlyTmD88Vdlz5" /></figure><p>You’ve probably tried ginseng. Maybe ashwagandha has made an appearance in your supplement stack. But <em>Rhodiola rosea</em>? That’s the adaptogen most people scroll right past, even though it might be exactly what they need.</p><p>Here’s the problem with treating all adaptogens as interchangeable: it’s like saying all exercise is the same. Yoga and sprinting both count as movement, but they produce very different physiological effects. Choose the wrong adaptogen, and you might feel more wired when you wanted calm, or more sedated when you needed sharp focus.</p><p>This article uses the two adaptogens you already know, ashwagandha and ginseng, as a reference point to understand where <em>Rhodiola rosea</em> fits in, and more importantly, when it might be the better choice for your specific needs.</p><h3>What Are Adaptogens?</h3><p>Adaptogens are a class of herbs that help the body handle stress, whether physical, mental, or emotional, without the crash that comes with stimulants or the fog that follows sedatives. The term was coined by Soviet scientist Nikolai Lazarev in 1947, and these compounds have been studied for decades for their ability to increase resistance to various stressors.</p><p>They work through multiple mechanisms: modulating the HPA axis (the body’s central stress response system, think of it as your body’s master dial for the stress response), regulating stress hormones, and supporting neurotransmitter function [1]. In essence, adaptogens don’t eliminate stress. They help the body handle it more efficiently.</p><p>The three most studied adaptogens are ashwagandha ( <em>Withania somnifera</em>), ginseng ( <em>Panax ginseng</em>), and <em>Rhodiola rosea</em>. And while all three are often lumped together, their active compounds — withanolides, ginsenosides, and salidroside and rosavins, respectively — produce very different effects in the body. We’ll start with <em>Rhodiola rosea</em>, the least familiar of the three, because understanding what it does first makes it much easier to see exactly what ashwagandha and ginseng are, and aren’t, doing by comparison.</p><h3>Rhodiola rosea : The “Perform Under Pressure” Adaptogen</h3><h4>1. What It Is and How It Works</h4><p><em>Rhodiola rosea </em>grows in some of the harshest environments on Earth — the frozen tundras of Siberia, the mountains of Scandinavia, and other high-altitude environments where most plants cannot survive. That resilience is exactly why it has been used to help humans do the same.</p><p>The plant contains two main groups of active compounds: salidroside, a sugar-bound molecule derived from the amino acid tyrosine, and rosavins, a group of compounds found exclusively in <em>Rhodiola rosea</em> and not in other <em>Rhodiola</em> species. Together, they regulate the stress response via the HPA axis and modulate levels of key neurotransmitters, including serotonin, dopamine, and norepinephrine [2]. At the cellular level, salidroside in particular has been shown to protect neurons from oxidative stress and support mitochondrial function — think of your mitochondria as the power plants inside each cell, and oxidative stress as the rust that accumulates when those plants run too hot for too long. Salidroside helps keep the machinery running cleaner, which matters especially during sustained mental or physical effort [3, 4].</p><p>A note on the research : While salidroside is a key active compound and a commonly used quality biomarker, the available clinical evidence for stress and cognitive outcomes largely comes from studies using the full extract. A small number of trials using isolated salidroside have begun to emerge, including a recent study in healthy active adults reporting improvements in exercise-related performance and fatigue [5], but these remain limited in scope and context. As with other botanical extracts such as green tea, individual compounds are often used as markers, but the overall biological effects cannot be attributed to a single molecule alone.</p><h4>2. What Does the Research Show?</h4><p>The clinical picture for <em>Rhodiola rosea</em> is notably specific: it performs best under conditions of stress-related mental fatigue — a different target than general anxiety or physical exhaustion. Across multiple trial designs, the pattern that emerges consistently is faster onset and stronger effects on cognitive performance under pressure than on mood or physical energy alone:</p><ul><li>Mental performance under stress : Standardized <em>Rhodiola rosea</em> extract significantly improved stress-related fatigue and mental performance compared to placebo, with benefits documented in both 28-day and 4-week trials [6, 7].</li><li>Anxiety and mood : A 14-day trial found significant reductions in self-reported anxiety, stress, anger, and confusion compared to baseline [8].</li><li>Physical endurance : A comprehensive review of <em>Rhodiola rosea</em>’s effects on exercise performance found evidence supporting improved time-to-exhaustion and reduced perceived exertion during physical activity [9].</li><li>Speed of onset : Clinical studies indicate that <em>Rhodiola rosea</em> can show measurable effects within 3–7 days [7] — notably faster than other adaptogens. This rapid onset is one of its distinguishing features.</li></ul><p>To understand where that speed and cognitive specificity actually stand out, it helps to look at how the two most established adaptogens differ.</p><h3>Ashwagandha: The Calming Adaptogen</h3><h4>1. What It Is and How It Works</h4><p>If <em>Rhodiola rosea</em> is about performing under pressure, ashwagandha is about reducing the pressure itself. This Ayurvedic herb has been used in India for over 3,000 years, and its active compounds, the withanolides, work through a meaningfully different set of mechanisms than salidroside and rosavins.</p><p>Ashwagandha primarily works by reducing cortisol levels and modulating GABA receptors. These receptors are the brain’s main inhibitory neurotransmitter system, which functions a bit like a neural volume knob, turning down the intensity of stress signals rather than helping you push through them [10]. It also influences serotonergic pathways, which connect to its consistently observed effects on mood and sleep. The net result is a distinctly calming profile, which is both its greatest strength and its clearest differentiator from <em>Rhodiola rosea</em>.</p><h4>2. What the Research Shows</h4><p>The clinical evidence for ashwagandha is among the most robust of any adaptogen, particularly for anxiety, cortisol reduction, and sleep:</p><ul><li><strong>Stress and anxiety:</strong> Multiple meta-analyses confirm significant reductions in stress and anxiety compared to placebo [11, 12], though effect sizes vary considerably across studies, and researchers flag that the evidence base still needs more rigorous, standardized trials before strong clinical recommendations can be made.</li><li><strong>Cortisol reduction:</strong> Multiple trials show meaningful reductions in serum cortisol alongside improvements in perceived stress, with effects becoming significant after 60 days of consistent use [13, 14].</li><li><strong>Sleep quality:</strong> Ashwagandha consistently improves both sleep onset and overall sleep quality across multiple trials, a finding that connects directly to its GABA-modulating mechanism [10].</li><li><strong>Speed of onset:</strong> Clinical improvements typically appear within 2 to 4 weeks, slower than <em>Rhodiola rosea</em> but with stronger and more consistent evidence specifically for anxiety and sleep.</li></ul><h3>Ginseng: The Energy Adaptogen</h3><h4>1. What It Is and How It Works</h4><p>has been used in traditional Chinese medicine for thousands of years, making it arguably the most recognized adaptogen in the world. Its active compounds, the ginsenosides, are a family of over 30 steroidal saponins that vary in structure and biological effect, which partly explains why ginseng’s clinical profile is broader and harder to pin down than either <em>Panax ginseng Rhodiola rosea</em> or ashwagandha.</p><p>Where salidroside and rosavins target stress-related mental fatigue, and withanolides dial down the stress response itself, ginsenosides work primarily on energy metabolism and physical resilience through multiple pathways [15]. The net effect is less about modulating mood or stress hormones and more about supporting the body’s baseline capacity to sustain energy.</p><h4>2. What the Research Shows</h4><p>The clinical evidence for ginseng is strongest for fatigue, particularly physical and disease-related fatigue:</p><ul><li><strong>Chronic fatigue</strong>: Multiple studies confirm significant improvements in fatigue symptoms compared to placebo [16, 17].</li><li><strong>Disease-related fatigue</strong>: American ginseng has guideline-level support from the American Society of Clinical Oncology as a recommended intervention for cancer-related fatigue, based on multiple randomized controlled trials [18]. This is the strongest level of clinical endorsement of any adaptogen for a specific condition.</li><li><strong>Cognitive performance</strong>: Evidence here is weaker and less consistent. Systematic reviews note that ginseng’s effects on mental fatigue and cognitive performance are less well-established than its effects on physical fatigue [15].</li><li><strong>Speed of onset</strong>: Effects typically emerge after 4 to 8 weeks of consistent use, the slowest of the three adaptogens covered here.</li></ul><h3>Which One Is Right for You?</h3><p>The honest answer is that none of these adaptogens is universally better than the others. No published randomized controlled trial has directly compared <em>Rhodiola rosea</em>, ashwagandha, and ginseng as isolated compounds in the same study population. The closest available evidence comes from a 2026 trial that tested a multi-herb formula containing <em>Rhodiola rosea</em> alongside ashwagandha, finding no meaningful difference in perceived stress outcomes between the two formulations [20] — a result that should be interpreted cautiously given that <em>Rhodiola rosea </em>was tested as part of a blend, not in isolation. Most comparative insights in this article are therefore drawn from parallel reading of independent trial bodies, not head-to-head data.</p><p>That limitation doesn’t make the choice arbitrary. The independent evidence for each adaptogen points in consistently different directions, and those patterns are what matter in practice. The right choice depends on what your version of stress actually looks like:</p><h4>“I need to focus and perform under pressure.”</h4><p><em>Rhodiola rosea </em>is the best-evidenced choice here. The clinical signal is specific to cognitive performance under stress, and onset can be as fast as 3 to 7 days [6, 7] — faster than any other adaptogen in this comparison.</p><h4>“I feel tired but wired.”</h4><p>That state where your body wants to collapse and your mind is still running tabs on everything you forgot to do — that’s not just stress, that’s cortisol not knowing when to clock out. Ashwagandha is the only one of the three with consistent evidence for lowering cortisol and improving sleep quality, which is exactly what this pattern needs [10, 13, 14].</p><h4>“I’m low energy and unmotivated.”</h4><p>When fatigue is the main issue rather than stress or mental performance, ginseng has the deepest evidence base, including the only guideline-level clinical endorsement of the three for fatigue management [17, 18].</p><h4>What about mixed states?</h4><p>occupies a useful middle ground. Unlike ashwagandha’s primarily calming profile or ginseng’s energy-focused action, <em>Rhodiola rosea Rhodiola</em> <em>rosea</em> appears to support both stress resilience and mental performance simultaneously, making it particularly relevant when mental fatigue and stress overlap [2].</p><h3>Safety and Quality: What to Know Before You Buy</h3><p>Clinical evidence consistently indicates that these three adaptogens are safe and well-tolerated, with no serious adverse events reported across the studies reviewed here. Side effects, when they occur, tend to be mild and transient: ashwagandha and ginseng can cause occasional digestive discomfort, while <em>Rhodiola rosea</em> is associated with minor nervous system symptoms in a small number of users [7, 13, 15].</p><p>Two interaction risks are worth flagging. <em>Rhodiola rosea</em> has a well-documented low potential for drug interactions [2]. Ginseng has been associated with potential bleeding risk for anyone on anticoagulant medication, and ashwagandha has shown activity on thyroid hormone levels in clinical studies — making both worth discussing with a prescribing physician if you are on relevant medication [17, 19].</p><h4>Can you combine adaptogens?</h4><p>Combining adaptogens is increasingly common, but the clinical evidence for specific pairings is still limited. What we do know is that multi-herb formulas containing <em>Rhodiola</em> <em>rosea </em>with other adaptogens such as ashwagandha, Schisandra, and holy basil have been tested and well-tolerated in recent trials [20]. Whether stacking produces additive benefits remains an open question, and individual responses can vary considerably. A healthcare practitioner can help determine whether a combination approach makes sense for your specific situation.</p><h4>The quality problem</h4><p>This is arguably the most overlooked consideration when choosing an adaptogen supplement. A 2026 analysis of commercial <em>Rhodiola rosea</em> products on the U.S. market found that salidroside content ranged from 0.01% to 3.08% across products, a 300-fold variation [21]. Some products also showed signs of adulteration with other Rhodiola species. Standardization and third-party testing are not optional details. They determine whether what is on the label is actually in the capsule.</p><h3>The Bottom Line</h3><p><em>Rhodiola rosea </em>is not the most famous adaptogen in the room. But if what you are dealing with is cognitive performance under stress, sustained mental fatigue, or the need to function clearly during demanding periods, the clinical evidence suggests it deserves a closer look.</p><p>The comparison with ashwagandha and ginseng is not about ranking. Each of these adaptogens has a distinct profile, a specific type of evidence, and a particular kind of person it is most likely to help. Ashwagandha works best when the goal is to lower the overall stress load and improve sleep. Ginseng is the strongest option when physical fatigue or post-illness recovery is the primary concern. And <em>Rhodiola rosea</em>, through salidroside and rosavins, appears to occupy a middle ground that is particularly relevant for the kind of stress most people actually face: the cognitive kind, under time pressure, and without the luxury of slowing down.</p><h3>References</h3><p>1. Panossian A. Understanding adaptogenic activity: specificity of the pharmacological action of adaptogens and other phytochemicals. Ann N Y Acad Sci. 2017;1401(1):49–64. doi:10.1111/nyas.13399</p><p>3. Zhong Z, Han J, Zhang J, Xiao Q, Hu J, Chen L. Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system. Drug Des Devel Ther. 2018;12:1479–1489. doi:10.2147/DDDT.S160776</p><p>5. Schwarz NA, Spence AL, Bredahl EC, et al. Effects of salidroside supplementation on exercise performance, fatigue, and recovery in healthy active adults: a randomized controlled trial. <em>Journal of Dietary Supplements.</em> 2024. doi:10.1080/15502783.2024. 2433744</p><p>6. Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009;75(2):105–112. doi:10.1055/s-0028–1088346</p><p>7. Edwards D, Heufelder A, Zimmermann A. Therapeutic effects and safety of Rhodiola rosea extract WS 1375 in subjects with life-stress symptoms: results of an open-label study. Phytother Res. 2012;26(8):1220–1225. doi:10.1002/ptr.3712</p><p>8. Cropley M, Banks AP, Boyle J. The effects of Rhodiola rosea L. extract on anxiety, stress, cognition and other mood symptoms. Phytother Res. 2015;29(12):1934–1939. doi:10.1002/ptr.5486</p><p>9. Tinsley GM, Jagim AR, Potter GDM, Garner D, Galpin AJ. Rhodiola rosea as an adaptogen to enhance exercise performance: a review of the literature. Br J Nutr. 2024;131(3):461–473. doi:10.1017/S0007114523001988</p><p>11. Akhgarjand C, Asoudeh F, Bagheri A, et al. Does ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022;36(11):4115–4124. doi:10.1002/ptr.7598</p><p>12. Alsanie SA, Alhodieb FS, Askarpour M. Effects of ashwagandha (Withania somnifera) on mental health in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Complement Ther Med. 2026;97:103325. doi:10.1016/j.ctim.2026.103325</p><p>15. Arring NM, Millstine D, Marks LA, Nail LM. Ginseng as a treatment for fatigue: a systematic review. J Altern Complement Med. 2018;24(7):624–633. doi:10.1089/acm.2017.0361</p><p>17. Li Z, Wang Y, Xu Q, et al. Ginseng and health outcomes: an umbrella review. Front Pharmacol. 2023;14:1069268. doi:10.3389/fphar.2023.1069268</p><p>18. Bower JE, Lacchetti C, Alici Y, et al. Management of fatigue in adult survivors of cancer: ASCO-Society for Integrative Oncology guideline update. J Clin Oncol. 2024;42(20):2456–2487. doi:10.1200/JCO.24.00541</p><p>19. Sharma AK, Basu I, Singh S. Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. <em>J Altern Complement Med. </em>2018;24(3):243–248. doi:10.1089/acm.2017.0183</p><p>20. McKinney E, Stewart J, Kewalramani R, Singh S. Effects of multi-herb and ashwagandha root formulas on stress modulation: a randomized, double-blind, placebo-controlled clinical study. Trials. 2026;27:205. doi:10.1186/s13063–026–09495–9</p><p><em>Originally published at </em><a href="https://troscriptions.com/blogs/main/rhodiola-rosea-vs-ashwagandha-and-ginseng"><em>https://troscriptions.com</em></a><em> on May 21, 2026.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e826e954d806" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Apigenin as a Natural Orexin Inhibitor: What It Means for Sleep]]></title>
            <link>https://medium.com/@lucia.g.forte/apigenin-as-a-natural-orexin-inhibitor-what-it-means-for-sleep-0bf9d5079cc2?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/0bf9d5079cc2</guid>
            <category><![CDATA[apigenin]]></category>
            <category><![CDATA[sleep]]></category>
            <category><![CDATA[natural-medicine]]></category>
            <category><![CDATA[orexin]]></category>
            <category><![CDATA[chamomile-tea]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Wed, 01 Apr 2026 16:44:14 GMT</pubDate>
            <atom:updated>2026-04-01T16:44:14.593Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/480/0*UkqoxDO90Y5esqLH" /></figure><p>You’re exhausted. It’s past midnight. Insomnia starts to wave at you again. As you stare at the ceiling, you find yourself remembering your mother’s old-school advice: “Have a cup of chamomile tea!”</p><p>Across cultures, chamomile has long been associated with relaxation, calmness, and improved sleep quality [1]. But beyond tradition and anecdote, an important scientific question remains: what is actually happening in the body when chamomile seems to help us unwind?</p><p>One of the key bioactive compounds found in chamomile is <a href="https://troscriptions.com/blogs/main/apigenin">apigenin</a>, a naturally occurring flavonoid also present in foods such as parsley, celery, and certain fruits [2,3]. This molecule is a biologically active compound with growing evidence for its role in physical and mental restoration. It has been widely studied for its neuroactive properties, including <a href="https://troscriptions.com/blogs/main/how-does-apigenin-affect-anxiety">anxiolytic</a> and sedative-like effects, often linked to its ability to modulate inhibitory neurotransmission [4,5].</p><p>At the same time, research in sleep neurobiology has identified another major player in wakefulness regulation: the orexin system. Pharmacological inhibition of orexin signaling is now an established approach for treating insomnia, raising interest in whether non-pharmacological compounds may influence this pathway [6,7].</p><p>Building on our earlier article on <a href="https://troscriptions.com/blogs/main/how-does-apigenin-affect-sleep">apigenin’s effects on sleep</a>, this article explores a more specific frontier: the hypothesis that apigenin acts as both a direct and an indirect inhibitor of orexin, effectively “dimming the lights” in your brain’s wakefulness center.</p><h3>Meet Orexin: The Brain’s Alertness Switch</h3><p>You fall asleep when the brain’s primary wake-promoting system — the orexin network — quiets down. Also known as the hypocretin signaling axis, it functions as the brain’s biological megaphone, broadcasting a constant signal to stay awake [6,8].</p><p>Produced exclusively by a small group of neurons in the lateral and posterior hypothalamus, the neuropeptides Orexin A and Orexin B project signals to almost every other wake-promoting center in the brainstem and forebrain [7,8]. These projections reach regions that regulate attention, motivation, autonomic activity, and alertness. Their primary job? To stabilize consolidated wakefulness and prevent you from accidentally falling into REM sleep (the dream-intensive phase of sleep) while, say, reading a very long blog post [7].</p><p>Two receptors mediate this effect: orexin receptor type 1 (OX1R) and orexin receptor type 2 (OX2R). Both contribute to arousal, but OX2R appears to be especially important for maintaining sustained wakefulness and organizing stable sleep-wake transitions [9]. When this signaling pathway fails, the result is narcolepsy, a disorder in which the brain cannot maintain a consistent boundary between sleep and wake [6].</p><h3>Why Can’t You Fall Asleep Even When You’re Exhausted?</h3><p>Being exhausted isn’t the same as being ready for sleep; if you’ve ever felt deep fatigue but your mind remains stuck in overdrive, you have experienced a state researchers call “hyperarousal” [6,10]. In this state, your orexin network is essentially stuck in the ON position at 2:00 AM, keeping arousal circuits active even when your body is tired. The result is a frustrating kind of mental static: you feel physically drained, yet neurologically wired.</p><p>For decades, most sleep medications have focused on “applying the biological brakes.” Benzodiazepines (such as Xanax ®or Valium ®) and Z-drugs (like Ambien ®or Lunesta ®) work by enhancing the brain’s primary inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), to dampen neural activity [4,11].</p><p>More recently, however, pharmacology has shifted strategy from simply “applying the brakes” to “turning off the ignition.” A newer class of drugs, known as Dual Orexin Receptor Antagonists (DORAs), doesn’t just sedate the brain; they specifically block the orexin receptors, OX1R and OX2R [6,7,9]. By silencing this “stay awake” signal at its hypothalamic source, DORAs help the brain transition more naturally into sleep.</p><p>This shift in sleep science reframes the ultimate question for natural health: Could a single plant-derived compound, such as apigenin, actually do both?</p><h3>What Is Apigenin and Why Is It Relevant for Sleep?</h3><p>While pharmaceutical companies are busy designing synthetic molecules to block orexin, nature has been quietly putting a candidate in your garden for millennia. Apigenin (4&#39;,5,7-trihydroxyflavone) belongs to the flavone subclass of polyphenols, a group of plant-derived molecules famous for their antioxidant and signaling properties [2,3,12].</p><p>Unlike many nutrients that sit in your stomach, apigenin is highly neuroactive. It is small and lipophilic enough to cross the <a href="https://troscriptions.com/blogs/main/blood-brain-barrier">blood-brain barrier</a>, allowing it to interact directly with neurons in the central nervous system [12].</p><p>Chemically, its electron-rich ring structure gives it a “promiscuous” bonding capacity, meaning it can bind to various receptors and enzymes, making it a multi-target solution for relaxation.</p><h3>Apigenin and Orexin: Exploring Direct and Indirect Mechanisms</h3><p>This multi-target profile raises a compelling question: could apigenin also modulate the orexin system? If so, current evidence suggests two complementary pathways: direct interactions at the receptor level and indirect effects on hyperarousal states that sustain orexin activity.</p><h4>1. Direct Mechanism: Can Apigenin Influence the Orexin Receptor?</h4><p>So, does apigenin actually “talk” to the hypothalamic wake center? Recent breakthroughs in bioinformatics suggest a fascinating — albeit preliminary — answer.</p><p>To explore this, researchers have utilized a sophisticated tool called Connectivity Mapping (CMap). CMap allows scientists to compare the “gene expression signatures” of different compounds, looking at the unique biological fingerprint a substance leaves on a cell [13].</p><p>When apigenin’s molecular signature is analyzed using these system-level approaches, it shows notable overlap with the pathways targeted by DORAs [10]. It’s as if the cell is consulting a similar chapter in the “how-to-sleep” manual, though certainly not the entire book.</p><p>To take it a step further, molecular docking studies (high-tech computer simulations that predict how a molecule “fits” into a specific receptor) were used to clarify <em>how</em>. These computational models suggest a favorable binding affinity for Orexin Receptor Type 2 (OX2R). By potentially docking into this receptor, apigenin may act as a natural key that blocks the lock and prevents arousal signals that keep the brain in a state of high alert [6,10].</p><p><strong>A Quick Reality Check:</strong> While these findings are incredible, we must keep our scientific hats on. Most of this evidence is currently <em>in silico</em> (computer-based) or based on network pharmacology [10]. While it represents a massive leap in understanding how apigenin might interact with the brain’s “wake” center, it serves as a promising roadmap for future human clinical trials rather than a conclusion. However, the fact that nature may have provided us with its own version of a DORA is nothing short of remarkable.</p><h4>2. Indirect Mechanisms: How Apigenin Reduces Hyperarousal</h4><p>Beyond the orexin system, apigenin works through multiple complementary pathways:</p><ul><li><em>The GABA Connection</em>: For years, apigenin has been recognized as a ligand for central benzodiazepine receptors located on the GABA-A receptor complex [4,6]. By enhancing GABA, apigenin helps quiet overactive neurons to induce a state of calm [5] — a mechanism explored in depth in our article on <a href="https://troscriptions.com/blogs/main/how-does-apigenin-affect-sleep">how apigenin affects sleep</a>. Establishing this baseline of neural stability is critical because a high-arousal orexin system is much harder to silence without the necessary inhibitory balance provided by the GABA system [6].</li><li><em>The MAO-A Inhibition</em>: Studies suggest that apigenin acts as a potent, reversible inhibitor of Monoamine Oxidase A (MAO-A), the enzyme responsible for breaking down neurotransmitters like <a href="https://troscriptions.com/blogs/main/serotonin">serotonin</a> and <a href="https://troscriptions.com/blogs/main/dopamine">dopamine</a>. In computational models, apigenin actually showed a higher binding affinity for MAO-A than common reference compounds. By stabilizing these “feel-good” chemicals, apigenin reduces the stress-driven signals that keep the orexin system in a state of hyper-alertness [12,14].</li><li><em>The NAD+ and Aging Link</em>: This is where the science gets high-tech. Apigenin is a potent inhibitor of CD38, an enzyme that “devours” NAD+, a coenzyme vital for cellular energy and DNA repair. As we age, CD38 levels rise, and NAD+ levels drop, often correlating directly with a decline in sleep quality. By inhibiting CD38, apigenin boosts NAD+levels, promoting cellular repair processes naturally coupled with deep, restorative sleep [2,15].</li><li><em>Reducing Neuroinflammation</em>: High arousal is often fueled by a “vicious cycle” of inflammation. Apigenin has been shown to inhibit pro-inflammatory cytokines (specifically IL-6 and TNF-α), which are signaling molecules that coordinate the body’s immune response. In individuals suffering from chronic sleep deprivation, these molecules are typically elevated. By “cooling down” this neuroinflammation, apigenin prevents the brain from staying in a permanent state of high alert, allowing for a more peaceful transition to rest [3,12,15].</li></ul><h3>Does Chamomile Actually Improve Sleep in Humans?</h3><p>Human clinical studies suggest that chamomile extracts (the most common source of apigenin) may improve subjective sleep quality and daytime functioning [1,2,9].</p><p>In a pilot study, 34 patients with primary insomnia took 270 mg of a high-grade chamomile extract twice daily. While it didn’t significantly change total sleep time for everyone, it showed a significant advantage in daytime functioning and reduced fatigue [16]. Patients felt more alert and “human” during the day, potentially reflecting improved sleep quality rather than increased total sleep time.</p><p>Additionally, research in elderly populations has confirmed that chamomile extract can significantly improve overall subjective sleep quality over a 28-day period [17].</p><h3>Apigenin vs. Conventional Sleep Aids</h3><p>Apigenin differs from conventional sleep medications in that it modulates arousal rather than forcing sedation. This translates into:</p><ul><li>Freedom from Dependence: Benzodiazepines and certain hypnotics are associated with physical dependence and withdrawal symptoms [17]. Apigenin, by contrast, has not demonstrated addictive potential in available research, suggesting a gentler modulation of sleep-related pathways [9,18].</li><li>No “Zombie” Hangover: Most pharmaceutical aids act like a sledgehammer on the brain’s GABA system, often leading to a morning hangover of grogginess and reduced mental performance. Apigenin, however, is associated with improved daytime functioning and reduced fatigue [9,16].</li><li>A “Clean” Safety Profile: Unlike barbiturates or synthetic DORAs that can have narrow safety margins, apigenin has demonstrated a favorable safety profile in available human studies [1,4].</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*tDh1gKn1UIQHrsXN" /></figure><h3>Practical Implications and Safety</h3><p>If you are considering apigenin as part of a sleep-support strategy, here are key factors to keep in mind:</p><ul><li>Dosage Matters: While a cup of tea is a great ritual, reaching a therapeutic dose for chronic insomnia would require large quantities of dried chamomile flowers. If you want consistent dosing, high-grade standardized extracts are much more practical for consistent results [1].</li><li>Strategic Timing: To support the natural decline of alertness signals in the evening, taking apigenin roughly 60 minutes before bed allows blood levels to peak as you transition into sleep [1,16].</li><li>Bioavailability: Although apigenin has limited solubility, your gut microbiota converts part of it into active metabolites. These compounds are cleared slowly, which may help sustain their biological effects across the sleep cycle [2,3].</li><li>Allergy Note: If you have a known allergy to ragweed, daisies, chrysanthemums, or other members of the <em>Asteraceae</em> family, consult a healthcare professional before using chamomile-derived products due to the risk of cross-reactivity [9,16].</li></ul><h3>Conclusion: Can Apigenin Really “Dim the Wake Signal?”</h3><p>Falling asleep is not about collapsing from exhaustion; it is about shifting the balance between arousal and inhibition.</p><p>Apigenin appears to influence that balance through both direct and indirect mechanisms. Emerging computational and transcriptomic analyses suggest a potential direct interaction with the orexin system, the brain’s central stabilizer of wakefulness. At the same time, decades of research support its indirect modulation of GABAergic signaling, monoamine metabolism, neuroinflammation, and NAD ⁺ biology — pathways that shape the broader landscape of sleep regulation.</p><p>The direct orexin link remains early-stage. But taken together, the evidence suggests that apigenin does not force sedation; it helps recalibrate the biological conditions that allow sleep to emerge naturally.</p><p>So, the next time someone suggests a cup of chamomile tea, you can smile with the secret knowledge that you aren’t just following an old wives’ tale. You may be engaging a multi-pathway system designed to help your brain transition gracefully into restoration.</p><p>If you’re a practitioner and interested in using apigenin as a sleep aid for your patients, check out <a href="https://troscriptions.com/products/tro-plus-somna">Tro+ Somna</a>, Troscriptions’ most potent sleep formula yet. It’s designed to tackle even the most challenging sleep disturbances. If your patients really struggle to fall asleep or stay asleep, before reaching for the prescription (or calling in a refill), Tro+ Somna may be their answer!</p><h3>References</h3><p>1. Kazemi A, Shojaei-Zarghani S, Eskandarzadeh P, Hashempur MH. Effects of chamomile (Matricaria chamomilla L.) on sleep: a systematic review and meta-analysis of clinical trials. <em>Complement Ther Med</em>. 2024;84:103071. doi: 10.1016/j.ctim.2024.103071.</p><p>2. Kramer DJ, Johnson AA. Apigenin: a natural molecule at the intersection of sleep and aging. <em>Front Nutr</em>. 2024;11:1359176. doi: 10.3389/fnut.2024.1359176.</p><p>3. Mushtaq Z, Sadeer NB, Hussain M, Mahwish, Alsagaby SA, Imran M, Mumtaz T, Umar M, Tauseef A, Al Abdulmonem W, Tufail T, Al Jbawi E, Mahomoodally MF. Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms. <em>Int J Food Prop</em>. 2023;26(1):1914–1939. doi: 10.1080/10942912.2023.2236329.</p><p>4. Bruni O, Ferini-Strambi L, Giacomoni E, Pellegrino P. Herbal remedies and their possible effect on the GABAergic system and sleep. <em>Nutrients</em>. 2021;13(2):530. doi: 10.3390/nu13020530.</p><p>5. Kim JW, Kim CS, Hu Z, Han JY, Kim SK, Yoo SK, Yeo YM, Chong MS, Lee K, Hong JT, Oh KW. Enhancement of pentobarbital-induced sleep by apigenin through chloride ion channel activation. <em>Arch Pharm Res</em>. 2012;35(2):367–373. doi: 10.1007/s12272–012–0218–4.</p><p>6. Hu Z, Oh S, Ha TW, Hong JT, Oh KW. Sleep-aids derived from natural products. <em>Biomol Ther</em>. 2018;26(4):343–349. doi: 10.4062/biomolther.2018.099.</p><p>7. Toplu A, Mutlu N, Erdeve ET, Sariyildiz Ö, Çelik M, Öz-Arslan D, Akman Ö, Molnár Z, Çarçak N, Onat F. Involvement of orexin type-2 receptors in genetic absence epilepsy rats. <em>Front Neurol</em>. 2023;14:1282494. doi: 10.3389/fneur.2023.1282494.</p><p>8. Suo L, Chang X, Zhao Y. The orexin-a-regulated Akt/mTOR pathway promotes cell proliferation through inhibiting apoptosis in pancreatic cancer cells. <em>Front Endocrinol</em>. 2018;9:647. doi: 10.3389/fendo.2018.00647.</p><p>9. Żełabowski K, Pichowicz W, Skowron I, Szwach J, Biedka K, Wesołowski M, Błaszczyk K, Ziobro O, Petrov W, Kukula-Koch W, Chłopaś-Konowałek A. The efficacy of melatonergic receptor agonists used in clinical practice in insomnia treatment: melatonin, tasimelteon, ramelteon, agomelatine, and selected herbs. <em>Molecules</em>. 2025;30(18):3814. doi: 10.3390/molecules30183814.</p><p>10. Sun Y, Zhao R, Liu R, Li T, Ni S, Wu H, Cao Y, Qu Y, Yang T, Zhang C, Sun Y. Integrated screening of effective anti-insomnia fractions of Zhi-Zi-Hou-Po decoction via Drosophila melanogaster and network pharmacology analysis of the underlying pharmacodynamic material and mechanism. <em>ACS Omega</em>. 2021;6(13):9176–9187. doi: 10.1021/acsomega.1c00445.</p><p>11. Shi Y, Dong JW, Zhao JH, Tang LN, Zhang JJ. Herbal insomnia medications that target GABAergic systems: a review of the psychopharmacological evidence. <em>Curr Neuropharmacol</em>. 2014;12(3):289–302. doi: 10.2174/ 1570159X11666131227001243</p><p>12. Mohammadkhanizadeh A, Sheibani M, Taherkhani S, Nourabadi D, Mohamadi-Zarch SM, Nikbakht F, Azizi Y. Protective effects of apigenin in neurodegeneration: an update on the potential mechanisms. <em>Brain Disord</em>. 2025;17:100189. doi: 10.1016/j.dscb.2025.100189.</p><p>13. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. <em>Science</em>. 2006;313(5795):1929–1935. doi: 10.1126/science.1132939.</p><p>14. Olayinka JN, Akawa OB, Ogbu EK, Eduviere AT, Ozolua RI, Soliman M. Apigenin attenuates depressive-like behavior via modulating monoamine oxidase A enzyme activity in chronically stressed mice. <em>Curr Res Pharmacol Drug Discov</em>. 2023;5:100161. doi: 10.1016/j.crphar.2023.100161.</p><p>15. Camacho-Pereira J, Tarragó MG, Chini CCS, Nin V, Escande C, Warner GM, Puranik AS, Schoon RA, Reid JM, Galina A, Chini EN. CD38 dictates age-related NAD decline and mitochondrial dysfunction through a SIRT3-dependent mechanism. <em>Cell Metab</em>. 2016;23(6):1127–1139. doi: 10.1016/j.cmet.2016.05.006.</p><p>16. Zick SM, Wright BD, Sen A, Arnedt JT. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. <em>BMC Complement Altern Med</em>. 2011;11:78. doi: 10.1186/1472–6882–11–78.</p><p>17. Adib-Hajbaghery M, Mousavi SN. The effects of chamomile extract on sleep quality among elderly people: a clinical trial. <em>Complement Ther Med</em>. 2017;35:109–114. doi: 10.1016/j.ctim.2017.09.010.</p><p>18. Shinomiya K, Inoue T, Utsu Y, Tokunaga S, Masuoka T, Ohmori A, Kamei C. Hypnotic activities of chamomile and passiflora extracts in sleep-disturbed rats. <em>Biol Pharm Bull</em>. 2005;28(5):808–810. doi: 10.1248/bpb.28.808.</p><p><em>Originally published at </em><a href="https://troscriptions.com/blogs/main/apigenin-as-an-orexin-inhibitor"><em>https://troscriptions.com</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=0bf9d5079cc2" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Does Sodium Bicarbonate Belong in Hydration Drinks?]]></title>
            <link>https://medium.com/@lucia.g.forte/does-sodium-bicarbonate-belong-in-hydration-drinks-0ae9a28ae1ef?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/0ae9a28ae1ef</guid>
            <category><![CDATA[sports]]></category>
            <category><![CDATA[sodium-bicarbonate]]></category>
            <category><![CDATA[food-and-drink]]></category>
            <category><![CDATA[hydration]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Tue, 10 Feb 2026 14:04:23 GMT</pubDate>
            <atom:updated>2026-02-10T14:04:23.151Z</atom:updated>
            <content:encoded><![CDATA[<p><strong>A Sports Science Perspective</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/480/0*pt4PFOcKAb2pzTgl" /></figure><p>If you’ve ever felt your legs burn and power drop despite being well hydrated, you’ve already seen the limits of traditional hydration strategies. Today, the question isn’t just “how much fluid was lost?”, but rather, “what’s happening inside the muscle while we replace it?”</p><p>In this context, sodium bicarbonate has re-emerged as an ingredient worth paying attention to. Understanding how it works and where its benefits and limitations lie sheds light on why some modern hydration formulas are starting to look beyond classic electrolytes.</p><h3>Hydration 1.0: The Pillars of Volume and Stability</h3><p>Classic hydration strategies focus on replacing water and key electrolytes, particularly sodium, lost through sweat. This approach remains essential for maintaining plasma volume, cardiovascular stability, and thermoregulation during exercise, forming the foundation of effective hydration practices [1].</p><p>However, hydration alone does not address all the physiological challenges associated with high-intensity or repeated efforts. Even when fluid balance is maintained, performance can still decline rapidly under demanding conditions.</p><h3>Hydration 2.0: Managing the Chemistry, Not Just the Fluids</h3><p>In practical terms, an athlete can be perfectly hydrated — and still metabolically uncomfortable.</p><p>This disconnect is most noticeable during short, intense efforts or repeated bursts of high effort, where fatigue arrives quickly despite adequate fluid intake because metabolic stress, rather than dehydration, becomes the primary limiting factor [2].</p><p>To meet energy demands during high-intensity exercise, the rate of ATP turnover (the body’s “energy currency”) increases sharply. A consequence of this process is the accumulation of hydrogen ions (H ⁺ ), which leads to a progressive drop in pH in the muscle and blood [3].</p><p>This shift in pH acts as a “ <em>saboteur</em>” to the muscle, interfering with enzyme activity, calcium handling, and muscle contractile function [4]. While lactate is often blamed, it is actually a partner that helps retard acidosis; the real culprit is the accumulation of these protons within the intracellular environment [4,5]. When an athlete’s natural buffering capacity is overwhelmed, they hit a physiological wall that water cannot fix.</p><p>In these demanding conditions, you don’t just need hydration, you need a metabolic fire extinguisher: this is where buffering systems come into play.</p><h3>What Is Sodium Bicarbonate and Why Does It Matter in Exercise?</h3><p>Sodium bicarbonate (NaHCO ₃ ) is a naturally occurring alkaline salt and a central component of the body’s primary extracellular buffering system [2]. Together with carbonic acid, bicarbonate helps regulate blood pH by neutralizing excess hydrogen ions. Under resting conditions, this system maintains acid-base balance within a narrow and tightly controlled range [6].</p><p>During high-intensity exercise, however, hydrogen ion production can exceed the body’s immediate buffering capacity [2,3]. As metabolic demand increases, the ability to maintain a stable pH becomes increasingly challenged. Sodium bicarbonate supplementation raises extracellular bicarbonate concentration, expanding the blood’s capacity to buffer the acid load generated during intense metabolic activity [7].</p><p>The mechanism is conceptually simple but physiologically meaningful: higher extracellular bicarbonate increases the gradient for hydrogen ion efflux from muscle cells into the bloodstream. By facilitating the removal of H ⁺ from the intracellular environment, bicarbonate helps delay the decline in intramuscular pH [4]. This supports continued glycolytic flux to keep generating ATP, preserves contractile muscle function, and may allow high-intensity exercise to be sustained for slightly longer [6,8].</p><p>Importantly, sodium bicarbonate does not reduce hydrogen ion production. Instead, it improves the body’s ability to manage the acid load that accompanies intense exercise [3].</p><p>If all this sounds very biochemical, that’s because it is. But the takeaway is simple: sodium bicarbonate does not provide energy, oxygen, or hydration <em>per se</em>. Instead, it helps maintain the chemical conditions under which energy production can continue. Think of it less as fuel and more as maintenance for the metabolic engine.</p><h3>What Does the Science Say About Sodium Bicarbonate Supplementation?</h3><p>To understand where sodium bicarbonate fits — and where it doesn’t — it helps to separate what the evidence supports from where its limitations begin.</p><blockquote>1. When Does Sodium Bicarbonate Improve Performance?</blockquote><p>The ergogenic effects of sodium bicarbonate have been extensively studied across a wide range of sports and exercise modalities [9]. Across systematic reviews and meta-analyses, a consistent pattern emerges: performance benefits are most likely when exercise is short, intense, and metabolically demanding [6].</p><p>Performance improvements are most reported in:</p><ul><li>High-intensity continuous exercise lasting approximately 1 to 8 minutes [9]</li><li>Repeated sprint and intermittent exercise [10]</li><li>Activities with a strong anaerobic glycolytic component [3]</li></ul><p>In these contexts, sodium bicarbonate supplementation has been associated with improvements in mean power output, peak power, and time to exhaustion [8,9]. Notably, bicarbonate does not increase maximal strength. Instead, it helps athletes sustain high-intensity work by delaying fatigue under conditions of rapid acid accumulation [11].</p><blockquote>2. What Can Go Wrong with Sodium Bicarbonate?</blockquote><p>Despite its strong evidence base in specific exercise contexts, sodium bicarbonate is not a universal performance enhancer. Outside high-intensity, anaerobic scenarios where acid accumulation is the primary limiting factor — such as longer-duration endurance exercise dominated by oxidative metabolism — performance benefits are often inconsistent or absent [4].</p><p>Even within appropriate contexts, individual responses vary widely between athletes. Some experience clear performance improvements, while others see little effect or experience gastrointestinal symptoms that offset any potential benefit [11,12]. Part of this variability likely reflects population bias in the literature, as most studies have focused on young, trained male athletes, with limited data in female athletes, older adults, or recreational populations [9,13].</p><p>Dose also matters. Meaningful buffering effects only occur when bicarbonate intake is sufficient to alter extracellular acid-base balance. Naturally bicarbonated mineral waters illustrate this limitation well. While they can modestly increase blood bicarbonate levels, their bicarbonate content is typically far below doses shown to enhance high-intensity performance. As a result, controlled trials show no meaningful improvements in anaerobic performance despite small physiological changes [14].</p><p>Beyond individual variability and dosing, tolerability remains the main barrier to real-world use. Gastrointestinal discomfort has long limited the practical adoption of sodium bicarbonate, helping explain why laboratory evidence has historically outpaced its use in competition settings.</p><p>In response, research has shifted from asking whether sodium bicarbonate works to asking how it can be used without sabotaging the athlete in the process. Rather than relying on a single, large acute dose, recent research has focused on refining how sodium bicarbonate is delivered and timed in practice. These approaches aim to preserve buffering capacity while reducing the likelihood of gastrointestinal side effects [4,7,10,15]. In practice, this has translated into several recurring strategies:</p><ul><li>Lower total doses (around 0.2 g/kg body mass) may offer a more tolerable alternative for sensitive athletes by reducing gastrointestinal symptoms</li><li>Split or “top-up” dosing, in which the total dose is divided, can improve pre-exercise alkalosis with fewer side effects</li><li>Co-ingestion with carbohydrate-rich meals helps slow gastric emptying and improves tolerance</li><li>Novel delivery systems, such as hydrogel carbohydrate systems, mini-tablets, and enteric-coated capsules, have been shown to substantially improve gastrointestinal tolerance compared with traditional capsules</li></ul><p>Taken together, the evidence supports sodium bicarbonate as an effective tool when metabolic demand and acid accumulation limit performance, but only when dose, delivery, and context are aligned.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*NiNSdNQZj_27UKU5" /></figure><h3>From Performance Supplement to Hydration Strategy</h3><p>At first glance, sodium bicarbonate might seem like the odd one out in a hydration formula. It doesn’t directly enhance fluid absorption, it doesn’t quench thirst, and it certainly isn’t a classic electrolyte. So why is it increasingly appearing in modern sports drinks?</p><p>The answer isn’t that bicarbonate suddenly became magical — it’s that our expectations for hydration have evolved. Modern hydration strategies are no longer designed solely to replace what is lost in sweat. Instead, they aim to support performance sustainability under demanding conditions, especially when training or competition involves performing, recovering, and doing it all over again [10,15].</p><p>In this context, modern hydration products are like Swiss Army knives, combining multiple functions in one bottle. Carbohydrates support energy availability; sodium helps maintain fluid balance and plasma volume, while buffering agents, such as bicarbonate, step in to help manage acid-base stress [1,4,15].</p><p>Seen through this lens, the inclusion of sodium bicarbonate is not about redefining hydration. It reflects a broader shift toward formulations that acknowledge the metabolic realities of intense exercise, particularly when fatigue is driven less by dehydration and more by acid accumulation.</p><h3>Conclusion: A Supporting Role, not a Silver Bullet</h3><p>So, where does sodium bicarbonate actually fit within hydration strategies?</p><p>The answer depends on context and on whether metabolic acidosis is actually the factor holding performance back.</p><p>Sodium bicarbonate is not a hydration ingredient in the traditional sense. It does not replace fluids, stimulate thirst, or function as a universal solution for endurance or heat-related performance decline. What it offers instead is targeted metabolic support, helping manage acid-base stress during specific scenarios where high-intensity or repeated efforts push buffering systems to their limits.</p><p>The evidence is clear that bicarbonate’s benefits depend on exercise modality, dosing strategy, individual tolerance, and formulation design. Without careful consideration of these factors, its inclusion risks adding complexity without meaningful benefit — or worse, sending the athlete on an unplanned trip to the bathroom halfway through warm-up.</p><p>In this way, sodium bicarbonate occupies a supporting role rather than center stage. It is not a silver bullet, but a conditional tool: useful when metabolic acidosis is a genuine limiting factor, unnecessary when it is not, and effective only when dose, delivery, and purpose are aligned.</p><p>Effective hydration strategies start by identifying the true limiter — and designing formulations that address it with intent, not assumption.</p><h4>References</h4><p>1. Siegler JC, Carr AJ, Jardine WT, Convit L, Cross R, Chapman D, Burke L, Ross M. The hyperhydration potential of sodium bicarbonate and sodium citrate. <em>Int J Sport Nutr Exerc Metab</em>. 2022;32(2):74–81. doi:10.1123/ijsnem.2021–0179.</p><p>2. de Oliveira LF, Dolan E, Swinton PA, Durkalec‑Michalski K, Artioli GG, McNaughton PA, Saunders B. Extracellular buffering supplements to improve exercise capacity and performance: a comprehensive systematic review and meta-analysis. <em>Sports Med</em>. 2022;52(3):505–526. doi:10.1007/s40279–021–01575- x.</p><p>3. Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. <em>Am J Physiol Regul Integr Comp Physiol</em>. 2004;287(3):R502-R516. doi:10.1152/ajpregu.00114. 2004.</p><p>4. Grgic J, Pedisic Z, Saunders B, Artioli GG, Schoenfeld BJ, McKenna MJ, Bishop DJ, Richard B. Kreider RB, Stout JR, Kalman DS, Arent SM, VanDusseldorp TA, Lopez HL, Ziegenfuss TN, Burke LM, Antonio J, Campbell BI. International Society of Sports Nutrition position stand: sodium bicarbonate and exercise performance. <em>J Int Soc Sports Nutr</em>. 2021;18(1):61. doi:10.1186/s12970–021–00458- w.</p><p>5. Jones AM, Wilkerson DP, DiMenna F, Fulford J, Poole DC. Muscle metabolic responses to exercise above and below the ‘critical power’ assessed using 31P-MRS. <em>Am J Physiol Regul Integr Comp Physiol</em>. 2008;294(2):R585-R593.</p><p>6. Hadzic M, Eckstein ML, Schugardt M. The impact of sodium bicarbonate on performance in response to exercise duration in athletes: a systematic review. <em>J Sports Sci Med</em>. 2019;18(2):271–281.</p><p>7. Gough LA, Sparks SA. The effects of a novel sodium bicarbonate ingestion system on repeated 4 km cycling time trial performance in well-trained male cyclists. <em>Sports Med</em>. 2024;54(12):3199–3210. doi:10.1007/s40279–024–02083- 4.</p><p>8. Souza Lino R, Souza Lagares L, Victor Coutinho Oliveira C, Oliveira Queiroz C, Lessa Teixeira Pinto L, Alberto Bastos Almeida L, Simas Bonfim E, Plácido Conceição dos Santos C. Effect of sodium bicarbonate supplementation on two different performance indicators in sports: a systematic review with meta-analysis. <em>Phys Act Nutr</em>. 2021;25(1):7–15. doi:10.20463/pan.2021.0002.</p><p>9. Grgic J, Grgic I, Del Coso J, Schoenfeld BJ, Pedisic Z. Effects of sodium bicarbonate supplementation on exercise performance: an umbrella review. <em>J Int Soc Sports Nutr</em>. 2021;18(1):71. doi:10.1186/s12970–021–00469- 7.</p><p>10. Gurton WH, King DG, Ranchordas MK, Siegler JC, Gough LA. Enhancing exercise performance and recovery through sodium bicarbonate supplementation: introducing the ingestion recovery framework. <em>Eur J Appl Physiol</em>. 2024;124(11):3175–3190. doi:10.1007/s00421–024–05578- 0.</p><p>11. Grgic J, Rodriguez RF, Garofolini A, Saunders B, Bishop DJ, Schoenfeld BJ, Pedisic Z. Effects of sodium bicarbonate supplementation on muscular strength and endurance: a systematic review and meta-analysis. <em>Sports Med</em>. 2020;50(7):1361–1375. doi:10.1007/s40279–020–01275- y.</p><p>12. Burke LM. Nutritional approaches to counter performance constraints in high-level sports competition. <em>Exp Physiol</em>. 2021;106(11):2304–2323. doi:10.1113/EP088188.</p><p>13. Saunders B, Farias de Oliveira L, Dolan E, Durkalec-Michalski K, McNaughton L, Giannini Artioli G, Alan Swinton P. Sodium bicarbonate supplementation and the female athlete: a brief commentary with small scale systematic review and meta-analysis. <em>Eur J Sport Sci</em>. 2021;21(9):1240–1250. doi:10.1080/17461391.2021. 1880649.</p><p>14. Hagele AM, Boring JL, Moon JM, Sunderland KL, Mumford PW, Kerksick CM. Naturally bicarbonated water supplementation does not improve anaerobic cycling performance or blood gas parameters in active men and women. <em>Nutrients</em>. 2023;15(24):5052. doi:10.3390/nu15245052.</p><p>15. Naderi A, Rothschild JA, Santos HO, Hamidvand A, Koozehchian MS, Ghazzagh A, Berjisian E, Podlogar T. Nutritional strategies to improve post-exercise recovery and subsequent exercise performance: a narrative review. <em>Sports Med</em>. 2025;55(6):1559–1577. doi:10.1007/s40279–025–02213- 6.</p><p><em>Originally published at </em><a href="https://troscriptions.com/blogs/main/sodium-bicarbonate-in-hydration"><em>https://troscriptions.com</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=0ae9a28ae1ef" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Tailor-made Nutrition Plan: The End of All Known Diets?]]></title>
            <link>https://medium.com/@lucia.g.forte/tailor-made-nutrition-plan-the-end-of-all-known-diets-8458b94b683e?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/8458b94b683e</guid>
            <category><![CDATA[disease]]></category>
            <category><![CDATA[nutrition]]></category>
            <category><![CDATA[diet]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[microbiome]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Tue, 13 Jan 2026 16:16:19 GMT</pubDate>
            <atom:updated>2026-01-13T16:16:19.087Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*zAn9bYLNq3AVPhoU" /></figure><blockquote>A review on the impact that diet has on the gut microbiome ecosystem, ultimately affecting health and disease treatment.</blockquote><p>The human gut microbiome, composed of bacteria, fungi, viruses, and protozoa, constitutes an intricate and dynamic ecosystem. Diet plays a crucial role in the composition and function of this microbiome, affecting health and the onset of disease. Understanding how different diets influence the microbiome is essential for making informed dietary choices and preventing diet-related diseases.</p><p>Prior research has focused on the effects of the gut microbiome on health and disease, considering diverse factors such as ethnicity, geographical location, immigration, and, of course, diet. In this work, the authors synthesised the most recent study results and took a step forward into the future by emphasising the importance of an individualised diet. Despite advances in microbiome research, significant challenges remain in understanding the interactions between diet and the microbiome.</p><h3>We are What We Eat</h3><p>The article analysed six popular diets:</p><p>· Mediterranean diet (rich in fruits, vegetables, fish, and olive oil),</p><p>· High-fibre diet,</p><p>· Plant-based diet,</p><p>· High-protein diet,</p><p>· Ketogenic diet (very low in carbs),</p><p>· Typical Western diet (often high in processed foods, sugar, and unhealthy fats).</p><p>The researchers analysed the nutrient profiles of each diet, including alcohol intake. But most importantly, they studied how each diet affects the balance and diversity of gut bacteria, and the differences were striking.</p><p>People who followed fibre-rich, plant-based diets tended to have more diverse and healthier gut microbiota, including polyunsaturated fatty acids and polyphenols that can enhance resistance to obesity, reduce inflammation, and regulate the immune system. A diverse microbiome is linked with better digestion, stronger immunity, and a lower risk of chronic diseases, having a marked impact on human health.</p><p>Researchers also found that the composition of the gut microbiome varies considerably between populations from different regions of the world, influenced by both dietary patterns and environmental factors. They noted that people living in rural areas with diets rich in natural, unprocessed foods had greater microbial diversity compared to those in urban settings with Western-style eating habits.</p><h3>Health and the Gut Microbiome</h3><p>The review goes further, discussing how diet can influence diseases like metabolic syndrome, chronic intestinal inflammation, and even colorectal cancer. Some specific diets, especially the Mediterranean diet, have been shown to reduce the effects of conditions such as type 2 diabetes, heart disease, irritable bowel syndrome, cognitive decline and depression.</p><p>Currently, scientists are moving toward the concept of precision nutrition, which involves tailoring a person’s diet to their unique biology, lifestyle, and gut microbiome. The goal is to create personalised nutrition plans that help people stay healthier, starting from the inside out.</p><h3>Not so Fast</h3><p>Although fewer than 15% of the global population resides in Europe or North America, over 70% of human microbiome research originates from these regions. As a result, low-income countries and the diseases that disproportionately affect them, such as malnutrition, remain considerably underrepresented.</p><p>Gaining a clearer understanding of how diet impacts health requires large-scale randomised controlled trials that reflect a wide range of factors, including geography, sex, ethnicity, and age. Given the complex and highly individualised nature of the gut microbiome’s relationship with health, a more inclusive and holistic research approach is essential to uncover how diet, microbial composition, and disease susceptibility are connected.</p><h3>Why Does it Matter?</h3><p>This comprehensive review offers insight into six major dietary categories and the diverse gut microbiota ecosystems they can support. Beyond diet, numerous historical, environmental, and psychological factors also influence overall human health.</p><p>Although microbiome research has made considerable progress, many challenges remain in deciphering the causal relationships between diet, the host, and the microbiome. To ensure consistency and reproducibility across diverse datasets and populations, results must be validated through cross-platform comparisons and clinical outcome assessments.</p><h3>Take Home Messages</h3><ol><li>Whole dietary regimes, such as the Mediterranean diet, plant-based diet, or Western diet, influence the composition of the gut microbiome.</li><li>Diet can have a positive effect on numerous diseases and conditions, such as type 2 diabetes, metabolic syndrome, heart disease, chronic intestinal inflammation and depression.</li><li>Exhaustive studies are needed to better understand the causal relationship between diet, host, and microorganisms for the development of precision nutrition and microbiome-based therapies.</li></ol><h4>This article was written as part of a series of ‘journal club’ summaries for Scientific Writers Ltd and is based on the following publication.</h4><p>Journal: Nature Reviews Microbiology</p><p>Title: The interplay between diet and the gut microbiome: implications for health and disease</p><p>First Author: Ross F. C., et al.</p><p>Journal: Nature Reviews Microbiology</p><p>Date online: 15 July 2024</p><p><em>Originally published at </em><a href="https://www.linkedin.com/pulse/tailor-made-nutrition-plan-end-all-known-7avfe/?trackingId=Elt0dxSDQ1GZPCQyZMA5Nw%3D%3D"><em>https://www.linkedin.com</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8458b94b683e" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Kava and Liver Toxicity: What We Actually Know]]></title>
            <link>https://medium.com/@lucia.g.forte/kava-and-liver-toxicity-what-we-actually-know-0a48a8f09854?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/0a48a8f09854</guid>
            <category><![CDATA[herbal]]></category>
            <category><![CDATA[research]]></category>
            <category><![CDATA[kava]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[liver]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Tue, 13 Jan 2026 16:09:18 GMT</pubDate>
            <atom:updated>2026-01-13T16:09:18.065Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/480/0*ZZc0zIW5iM7H9YNw" /></figure><p>If you’ve ever typed “is kava bad for your liver?” into a search bar, you know exactly how chaotic the results can be. On one side, you’ll find headlines sounding the alarm; on the other, centuries of safe, deeply rooted traditional use across the South Pacific. It’s a bit like watching two different movies on the same screen: one a thriller, the other a calm island documentary. Between those two narratives sits a complicated mix of research findings, regulations, case reports, and misconceptions that have proven surprisingly persistent.</p><p>So, what does the evidence actually say?</p><p>When you unpack the data, the picture becomes far more nuanced and less dramatic than the early 2000s headlines suggested. This is where things get messy. Several countries imposed restrictions after reports of hepatotoxicity, but later reviews found that many cases couldn’t clearly attribute liver injury to kava itself. Others highlighted very specific circumstances associated with the reported liver cases: non-traditional solvent extracts, poor-quality or adulterated products, individual susceptibility due to pre-existing risk factors [1,2].</p><p>The goal here is to clarify what we actually know today: what sparked the controversy, how different types of kava products differ in risk, what mechanisms might explain liver injury, and what modern evidence says about real-world safety.</p><h3>What Is Kava and How Does It Work in the Body?</h3><p><a href="https://troscriptions.com/blogs/main/kava"><em>Piper methysticum</em> — better known as kava or kava kava</a>- is a sterile cultivar native to the South Pacific. It doesn’t reproduce from seed; instead, it spreads through cuttings, which helped shape a rich diversity of cultivated varieties (“cultivars”) across Oceania [3,4]. Only the peeled roots and rhizomes are traditionally used.</p><p>As researchers began to look more closely at what makes these roots so biologically active, attention quickly centered on kava’s signature compounds: the kavalactones. This is where things get interesting, because kavalactones don’t just “relax you;” they tune specific neural circuits in ways modern pharmacology finds genuinely compelling. The major kavalactones are <a href="https://troscriptions.com/blogs/main/kavain">kavain</a>, dihydrokavain, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin, and they act on multiple targets in the central nervous system. They modulate <a href="https://troscriptions.com/blogs/main/tagged/gaba">GABA</a> (short for gamma-aminobutyric acid, the neurotransmitter that helps dial down excessive neuronal firing so your system can shift out of high-alert mode) and influence voltage-gated sodium and calcium channels, mechanisms that collectively contribute to kava’s anxiolytic, muscle-relaxant, and mood-supporting effects [5,6]. Importantly, these actions tend to produce calm without the heavy sedation or cognitive dulling associated with some pharmaceutical anxiolytics.</p><p>Kava’s biological reach doesn’t stop there. Research highlights anti-inflammatory, analgesic, and antioxidant properties, and some studies even explore anticancer potential [7].</p><h3>Traditional Uses: Social, Ritual, and Therapeutic</h3><p>In Pacific cultures, kava is far more than a relaxing beverage. It plays a central role in ceremonies and diplomacy, spiritual practices, and social bonding. The traditional drink is prepared by macerating peeled roots in cold water [8], a gentle extraction method that yields a mild, slow-acting beverage with a well-characterized safety record [3,4].</p><p>Within these cultural settings, kava is valued for its ability to promote relaxation, sociability, mental clarity, and a mild sense of euphoria without impairing cognition. These same properties explain why kava has attracted medical interest as a natural option for supporting mood balance and managing <a href="https://troscriptions.com/blogs/main/can-kava-help-with-anxiety">anxiety</a>, stress, sleep difficulties, and premenstrual discomfort. Traditional use doesn’t replace clinical data, but it provides a long-standing real-world context for understanding both its benefits and its safety profile.</p><h3>Modern Preparations: Where Things Began to Diverge</h3><p>The version of kava that entered Western markets in the 1990s and 2000s looked nothing like the traditional beverage. Instead of a single, culturally consistent preparation, kava began to appear in multiple forms:</p><ul><li>Traditional aqueous beverages (root-only, kneaded or ground in water)</li><li>Standardized extracts (often acetone- or ethanol-based, sometimes made from aerial plant parts)</li><li>Tinctures (alcohol-based)</li><li>Capsules (powdered root or extracts)</li></ul><p>At that point, the difference was no longer just about <em>how</em> kava was consumed, but <em>what</em> was being extracted and from which parts of the plant. Traditional use relies on water-based extraction and peeled roots only, while many commercial products shifted toward solvent-based methods, mixed plant material, and non-standardized sourcing.</p><p>These changes matter. Extraction solvents can alter the chemical profile, potentially concentrating compounds that traditional preparations kept at very low levels. Pacific Island communities have long distinguished kava cultivars by chemotype [9], with some considered unsuitable for regular consumption, subtleties that Western manufacturing historically overlooked [10]. In addition, some commercial extracts included leaves and stems, which contain alkaloids absent from the root and linked to toxicity [1,11].</p><p>Taken together, these shifts in preparation methods and plant material help explain why the modern safety story became so complicated.</p><h3>The Early 2000s Hepatotoxicity Wave</h3><p>Between 1999 and 2002, several countries reported cases of liver injury potentially linked to kava. The U.S. Centers for Disease Control and Prevention (CDC) documented reports from Germany, Switzerland, and the U.S. [2]. Some cases involved severe outcomes, including liver failure requiring transplantation, prompting regulatory agencies in Europe, Canada, and Australia to restrict or ban kava products. But once researchers dug into the data, a more nuanced picture emerged, not exactly a smoking gun. Problems with the original case reports included:</p><ul><li>Incomplete patient histories [12,13]</li><li>Missing product information [12]</li><li>Co-consumption of alcohol or hepatotoxic drugs (comedication) [10,12,13]</li><li>Pre-existing liver disease (such as autoimmune hepatitis, primary biliary cirrhosis, or viral infection) [12,13]</li><li>Use of non-traditional extracts (such as those prepared with ethanol or acetone, in contrast to the traditional water-based extract) [10–14]</li><li>Uncertain dosages and durations of use [12,13]</li><li>Questionable product quality [10,12,15]</li></ul><p>Taken together, the evidence looked less like a clear verdict and more like a collection of warning flags. When later reviews revisited these cases, clear causal links were often missing [1,10,13,15]. For example, in a critical analysis of 26 suspected hepatotoxicity cases in Germany and Switzerland, only 3 were considered “probable” and 6 “possible,” and in 79% of the cases, the dose and/or duration exceeded regulatory recommendations [13].</p><p>Furthermore, some products used stem peelings or aerial parts of the plant, which are known to contain alkaloids like pipermethystine, associated with greater hepatic risk [1,9,11,14,15]. Others may have been contaminated by mycotoxins or were improperly stored, which was considered a more likely cause than synthetic solvents [1,9,16].</p><p>By 2014, accumulating evidence led German courts to lift the national ban, citing insufficient proof of inherent toxicity in properly prepared kava [17].</p><h3>Possible Biological Pathways Behind the Reported Liver Cases</h3><p>Researchers have explored several hypotheses to explain how kava might contribute to liver injury in rare circumstances. None fully explains all cases, but together they outline plausible pathways.</p><blockquote>Animal Clues: Context Matters More Than the Headlines</blockquote><p>Early toxicology studies in animals did raise some eyebrows. At very high doses, certain kavalactones could nudge liver enzymes or stress liver cells [1,2]. But many of these studies used doses far above human exposure, relied on ethanol or acetone extracts, and sometimes included aerial parts or non-noble cultivars. So yes, there were biological “signals,” but they were more like stress-testing the system than reflecting real-world human use.</p><blockquote>Metabolism Insights: How the Liver Handles Kavalactones</blockquote><p>Certain kavalactones, especially methysticin derivatives, undergo bioactivation by liver enzymes. Reactive metabolites may cause extra oxidative cellular stress in susceptible individuals with genetic polymorphisms, concurrent medications, or existing liver disease [18].</p><blockquote>Non-Traditional Compounds: Flavokavain B and Friends</blockquote><p>One of the biggest “ <em>aha</em>” moments came from studying flavokavains, compounds that appear in higher amounts in non-noble cultivars, leaves, and stems, and solvent-based extracts. Flavokavain B in particular has shown hepatotoxic effects in cell studies ( <em>in vitro</em>) [11,17].</p><blockquote>Drug Interactions and Liver Enzyme Inhibition</blockquote><p>Kava can inhibit CYP3A4, one of the major enzymes the liver uses to process medications.</p><p>This doesn’t inherently mean toxicity, but it does mean that if someone is taking acetaminophen, isoniazid, oral contraceptives, alcohol, or other medications with hepatic load, the metabolic “traffic jam” might make the liver more vulnerable [19].</p><blockquote>Idiosyncratic Reactions: The Rare Wild-Card Events</blockquote><p>Some reported cases resemble classic idiosyncratic liver injury: extremely rare, unpredictable, and not clearly tied to the amount consumed [8]. This pattern appears with many herbal and even prescription products, meaning that a tiny fraction of people may respond atypically due to genetic or immunologic factors.</p><blockquote>Contamination, Adulteration, and Product Quality</blockquote><p>This is the least glamorous but often the clearest explanation. Poor-quality products may contain mold toxins (such as aflatoxins or ochratoxin A), incorrect plant parts (stem peelings or aerial tissues), misidentified cultivars, or solvent residues. Given that these contaminants are themselves hepatotoxic, several cases likely had nothing to do with kava chemistry <em>per se</em>.</p><p>Mechanistically, then, kava’s risk profile depends heavily on chemotype, cultivar, extraction method, and individual susceptibility.</p><h3>What High-Quality Evidence Actually Shows</h3><p>When you step away from case reports and instead focus on controlled clinical trials, the picture changes significantly.</p><blockquote>Anxiolytic Efficacy and Trial Safety</blockquote><p>Randomized controlled trials (RCTs) use standardized products and controlled subject groups, which makes their safety and efficacy findings far more reliable.</p><p>Multiple trials show that standardized kava extracts can significantly reduce symptoms of generalized anxiety disorder compared to placebo [1,10,20]. One study using a standardized extract at 210 mg per day over 24 weeks reported a 68.4% reduction in anxiety scores [1,9].</p><p>Importantly, in high-quality trials, severe liver injury is extremely rare. For example, a six-week RCT using a standardized aqueous extract found no significant differences in liver function tests between the kava and placebo groups [10]. A 2018 clinical pharmacology review also concluded that while hepatotoxicity is possible, it appears to be rare and may depend on non-traditional preparations or individual susceptibility [1].</p><p>Several studies also note that kava does not typically cause cognitive impairment or withdrawal issues, a meaningful contrast with some synthetic anxiolytics [6,10].</p><p>You can read more about kava and anxiety in our dedicated blog article <a href="https://troscriptions.com/blogs/main/can-kava-help-with-anxiety">here</a>.</p><blockquote>The Quality Control Factor and the Rejected Paradox</blockquote><p>The early safety controversy led to the so-called “Pacific kava paradox,” which suggested that liver toxicity occurred only with Western solvent-based extracts and not with traditional water-based preparations [16]. This idea has now been rejected: analyses show that hepatotoxicity cases have also been linked to traditional aqueous extracts in New Caledonia, Australia, the United States, and Germany [16,21]. Current evidence points to poor raw material quality as the most plausible driver of rare toxicity [1,12,16], regardless of the extraction solvent used.</p><h3>What Modern Regulatory Agencies Conclude</h3><p>Across agencies, the message is consistent: kava can be used safely when products meet high-quality standards, and consumers understand potential risks. Here’s how major regulators frame it:</p><ul><li>World Health Organization (WHO) recognizes a potential risk but emphasizes that quality standards significantly reduce it [22].</li><li>European Medicines Agency (EMA) acknowledges that evidence is insufficient to justify a full ban and calls for strict quality controls [23].</li><li>U.S. Food and Drug Administration (FDA) maintains safety notifications but does not prohibit kava [24].</li><li>U.S. National Center for Complementary and Integrative Health (NCCIH) notes that kava may help with anxiety but advises caution because liver injury, though uncommon, has been reported [25].</li></ul><h3>Conclusion: A More Accurate, Less Dramatic Picture</h3><p>Early reports created a lasting impression that kava poses a meaningful risk to the liver. But when the full body of evidence is examined, that risk appears to be extremely low for properly prepared, high-quality kava products used by healthy adults.</p><p>The takeaway is practical. Choose products made from peeled noble-root material and backed by third-party testing (like Troscriptions!). These show a far safer profile than the poorly characterized preparations implicated in early reports. If unusual symptoms appear, stop use and seek medical evaluation, as you would with any bioactive compound.</p><p>A clear, evidence-driven perspective not only helps consumers make informed choices; it also raises the standard for how botanicals are discussed in modern health science.</p><h3>References</h3><ol><li>White CM. The pharmacology, pharmacokinetics, efficacy, and adverse events associated with kava. J Clin Pharmacol. 2018;58:1396–1405. doi:10.1002/jcph.1263</li><li>Centers for Disease Control and Prevention (CDC). Hepatic toxicity possibly associated with kava-containing products-United States, Germany, and Switzerland, 1999–2002. MMWR Morb Mortal Wkly Rep. 2002;51:1065–1067.</li><li>Lindstrom L. Kava: From Ethnology to Pharmacology. 1st ed. CRC Press; 2004. doi:10.1201/9781420023374</li><li>Lebot V, Merlin M, Lindstrom L. Kava: The Pacific Drug. Yale University Press; 1992.</li><li>Chua HC, Christensen ETH, Hoestgaard-Jensen K, et al. Kavain, the major constituent of the anxiolytic kava extract, potentiates GABA_A receptors: functional characteristics and molecular mechanism. PLoS One. 2016;11:e0157700. doi:10.1371/journal.pone.0157700</li><li>Dinh LD, Simmen U, Berger Bueter K, et al. Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Planta Med. 2001;67:306–311. doi:10.1055/s-2001–14334</li><li>Tamta N, Ojha A, Belwal R, et al. Phytochemistry and pharmacological potential of Piper methysticum: influence of plant parts and implications for neurodegenerative disorders. Int J Environ Sci. 2025;11:415–425. doi:10.64252/psansa17</li><li>Ulbricht C, Basch E, Boon H, et al. Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Expert Opin Drug Saf. 2005;4:779–794. doi:10.1517/14740338.4.4.779</li><li>Soares RB, Dinis-Oliveira RJ, Oliveira NG. An updated review on the psychoactive, toxic and anticancer properties of kava. J Clin Med. 2022;11(14):4039. doi:10.3390/jcm11144039</li><li>Sarris J, Stough C, Teschke R, et al. Kava for the treatment of generalized anxiety disorder: RCT analysis of adverse reactions, liver function, addiction, and sexual effects. Phytother Res. 2013;27:1723–1728. doi:10.1002/ptr.4916</li><li>Teschke R, Sarris J, Lebot V. Kava hepatotoxicity solution: a six-point plan for new kava standardization. Phytomedicine. 2011;18:96–103. doi:10.1016/j.phymed.2010.10.002</li><li>Teschke R. Kava hepatotoxicity: a clinical review. Ann Hepatol. 2010;9(3):251–265.</li><li>National Institute of Diabetes and Digestive and Kidney Diseases. Kava kava. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD: NIDDK; 2012-. Updated April 10, 2018.</li><li>Moulds RF, Malani J. Kava: herbal panacea or liver poison? Med J Aust. 2003;178(9):451–453. doi:10.5694/j.1326–5377.2003.tb05289.x</li><li>Teschke R, Sarris J, Glass X, Schulze J. Kava, the anxiolytic herb: back to basics to prevent liver injury? Br J Clin Pharmacol. 2011;71(3):445–448. doi:10.1111/j.1365–2125.2010.03775.x</li><li>Teschke R, Sarris J, Schweitzer I. Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited. Br J Clin Pharmacol. 2012;73(2):170–174. doi:10.1111/j.1365–2125.2011.04070.x</li><li>Kuchta K, Schmidt M, Nahrstedt A. German kava ban lifted by court: the alleged hepatotoxicity of kava (Piper methysticum) as a case of ill-defined herbal drug identity, lacking quality control, and misguided regulatory politics. Planta Med. 2015;81:1647–1653. doi:10.1055/s-0035–1558295</li><li>Wang P, Zhu J, Shehu AI, et al. Enzymes and pathways of kavain bioactivation and biotransformation. Chem Res Toxicol. 2019;32:1335–1342. doi:10.1021/acs.chemrestox.9b00098</li><li>Nascimento MDL, Do Nascimento SB, Lima EDSP, et al. Evaluation of the effects of extracts containing Valeriana officinalis and Piper methysticum on the activities of cytochrome P450 3A and P-glycoprotein. Planta Med. 2024;90:792–800. doi:10.1055/a-2360–4808</li><li>Sarris J, LaPorte E, Schweitzer I. Kava in the treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2011;31:643–647. doi:10.1097/JCP.0b013e3182312981</li><li>Russmann S, Barguil Y, Cabalion P, et al. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur J Gastroenterol Hepatol. 2003;15(9):1033–1036. doi:10.1097/00042737–200309000–00015</li><li>World Health Organization. Assessment of the Risk of Hepatotoxicity with Kava Products. WHO Technical Report. World Health Organization; 2007.</li><li>European Medicines Agency. Assessment Report: Kava. European Medicines Agency; 2014.</li><li>U.S. Food and Drug Administration. Consumer advisory on kava-containing dietary supplements. U.S. Food and Drug Administration; 2002. Updated 2019.</li><li>National Center for Complementary and Integrative Health. Kava. National Institutes of Health. Updated 2025</li></ol><p><em>Originally published at </em><a href="https://troscriptions.com/blogs/main/kava-and-liver-toxicity"><em>https://troscriptions.com</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=0a48a8f09854" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What happens if I eat moldy cheese?]]></title>
            <link>https://medium.com/@lucia.g.forte/what-happens-if-i-eat-moldy-cheese-b77fe122435f?source=rss-9f85ec18f74d------2</link>
            <guid isPermaLink="false">https://medium.com/p/b77fe122435f</guid>
            <category><![CDATA[food]]></category>
            <category><![CDATA[safety]]></category>
            <category><![CDATA[cheese]]></category>
            <dc:creator><![CDATA[Lucía González Forte]]></dc:creator>
            <pubDate>Thu, 09 Oct 2025 16:06:18 GMT</pubDate>
            <atom:updated>2025-10-09T16:06:18.509Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*UD16bKRYvx5Kna8oXgCKjQ.png" /><figcaption>What happens if I eat moldy cheese</figcaption></figure><p>Cheese is, I dare say, milk’s fanciest upgrade. We’ve all been there: you go to the grocery store and buy some cheeses — a few days later, you find yourself looking at moldy cheese in your fridge and asking the question, is this cheese still good?</p><p>Spotting mold on food usually means it’s time to toss it. But, as a certified Fromagelier and food science specialist, I can tell you with cheese (luckily!) that may not always be the case. In this article, we’ll explore whether moldy cheese is still safe to eat and how to tell the good from the bad.</p><h3>Good Mold Vs. Bad Mold: What’s Lurking In Your Food?</h3><p>Certain molds play a key role in cheese production. For example, species like <em>Penicillium roqueforti</em> and <em>Penicillium camemberti</em> are intentionally added to cheeses such as blue cheeses, Camembert and Brie. These molds contribute to the texture, flavor, and appearance of the final product and are considered safe for consumption [1].</p><p>In contrast, mold growth on other types of cheeses such as soft fresh cheeses like cream cheese, cottage and mascarpone, should not be there. The same goes for any kind of cheese that’s shredded, crumbled or sliced, and the recommendation from USDA experts is to discard it [2].</p><h3>Moldy Cheese: Save It Or Toss It?</h3><p>Mold on cheese isn’t always a dealbreaker, but it does depend on the guest list. If you spot unexpected fuzz on your cheese, the first thing to consider is what kind of cheese you’re dealing with. Fresh, soft varieties like ricotta, chèvre, or mascarpone are particularly vulnerable. Their high moisture content means that once mold appears, it’s likely taken over the whole thing. Best not to negotiate — just let it go.</p><p>Soft cheeses like Brie or Port Salut can sometimes be saved with a careful trim of about a quarter inch around the moldy area. Hard, aged cheeses like cheddar or Parmesan are more forgiving because of their low moisture, and mold usually stays on the surface and can be cut away without drama. However, if your cheese smells like ammonia or has turned slimy, mold is the least of your problems. That one’s going straight to the bin, no questions asked.</p><h3>What If I Ate Moldy Cheese?</h3><p>Dangerous molds can produce mycotoxins, that is a fact. However, various studies [3] have shown that the levels of mycotoxins found in cheese are generally very low. Combined with the fact that people are unlikely to consume large amounts of contaminated cheese, this suggests that mycotoxins in cheese do not pose a significant health risk. Additionally, your stomach’s acidity is usually strong enough to destroy mold spores before they can cause any harm.</p><p>That said, mold growing on soft cheeses can carry harmful bacteria such as <em>E. coli</em>, <em>Listeria</em>, <em>Salmonella</em>, and <em>Brucella</em>, all of which are known to cause food poisoning [4, 5]. Symptoms may include vomiting, stomach pain, and diarrhea, and in severe cases, can even be life-threatening.</p><p>So, if you’ve ingested moldy cheese, don’t panic, the experts say. Unless you’re immunocompromised or ate a very large quantity of mold, you’ll probably be OK, but watch for severe gastrointestinal symptoms or signs of an allergic reaction, in that case seek medical attention.</p><h3>How Can I Properly Store Cheese To Prevent Molding?</h3><p>Storing cheese correctly and consuming it within a reasonable timeframe is the most effective way to prevent the growth of unwanted mold. The first step is to wrap the cheese appropriately — ideally in cheese paper, which allows it to breathe while protecting it from excessive moisture. If cheese paper isn’t available, tightly wrapping it in plastic wrap is a practical alternative. Label the package with the cheese type and purchase date for quality control and keep it in the crisper drawer of your refrigerator, as it provides a stable environment in terms of temperature and humidity.</p><p>When dealing with mold-grown cheeses, such as blue cheeses, use the characteristic blue or green veining as your reference point. If you notice any additional mold growth that appears fuzzy, unusually colored, or texturally inconsistent, it’s best to err on the side of caution.</p><p>So next time you find a fuzzy surprise on your cheese, you’ll know whether to savor or say goodbye. Have you ever braved eating moldy cheese? Share your story or questions in the comments — let’s keep the conversation going! 🚀</p><p><em>⚡️ Hi! I’m Lucía González-Forte and I help brands and experts create clear, credible, and SEO-friendly science communication. Interested in collaborating? Send me a DM and let’s get started! 💡</em></p><h3>References</h3><p>[1] Hymery, N., Vasseur, V., Coton, M., Mounier, J., Jany, J.‑L., Barbier, G., &amp; Coton, E. (2014). <em>Filamentous fungi and mycotoxins in cheese: A review</em>. <em>Comprehensive Reviews in Food Science and Food Safety, 13</em>(4), 437–456. <a href="https://doi.org/10.1111/1541-4337.12069">https://doi.org/10.1111/1541-4337.12069</a></p><p>[2] U. S. Department of Agriculture (USDA), Food Safety and Inspection Service. (2013, August 22). <em>Molds on Food: Are They Dangerous?</em> Retrieved June 18, 2025, from <a href="https://www.fsis.usda.gov/food-safety/safe-food-handling-and-preparation/food-safety-basics/molds-food-are-they-dangerous">https://www.fsis.usda.gov/food-safety/safe-food-handling-and-preparation/food-safety-basics/molds-food-are-they-dangerous</a></p><p>[3] Dobson, A. D. W. (2017). Mycotoxins in cheese. In P. L. H. McSweeney, P. F. Fox, P. D. Cotter, &amp; D. W. Everett (Eds.), <em>Cheese</em> (4th ed., pp. 595–601). Academic Press. <a href="https://doi.org/10.1016/B978-0-12-417012-4.00023-5">https://doi.org/10.1016/B978-0-12-417012-4.00023-5</a></p><p>[4] Canadian Paediatric Society. (2008). Foodborne infections. <em>Paediatrics &amp; Child Health, 13</em>(9), 779–788. <a href="https://doi.org/10.1093/pch/13.9.779">https://doi.org/10.1093/pch/13.9.779</a></p><p>[5] Chlebicz, A., &amp; Śliżewska, K. (2018). Campylobacteriosis, salmonellosis, yersiniosis, and listeriosis as zoonotic foodborne diseases: A review. <em>International Journal of Environmental Research and Public Health, 15</em>(5), 863. <a href="https://doi.org/10.3390/ijerph15050863">https://doi.org/10.3390/ijerph15050863</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b77fe122435f" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>